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ABSTRACT 
The carboxy terminal of the y-chain of human flbrtnogen contains at least 
three biologically. important functional domains: 
(i) the flbrinogen y-chain polymerisation centre, 
(ii) the platelet receptor domain and 
(iii) the site for staphyloccocal clumping. 
The nature of the site specificity of these interactions necessitates the 
existence of a preferred conformation for this region, the nature of which 
has yet to be clearly established. 
A novel zinc metalloproteinase isolated from puff adder venom (PAV 
protease) capable of specifically cleaving the di-y-chain of transglutaminase 
(Factor Xllla) catalysed crosslinked plasmin derived D-dimer into apparently 
symmetrical monomers has been described. The activity is fibrin specific 
and displays an unusual site specificity for the y-carboxy terminal domains 
within the crosslink region. The activity was reported to be potentiated by 
zinc. 
The effect of zinc on the digestion of D-dimer by PAV protease was 
evaluated by SDS-PAGE and by a fluorimetric technique utilising a 
fluorescent dansylcadaverine conjugate of the substrate (f-D-dimer). A 
differential zinc binding study determined that the potentiation of activity by 
zinc was due to a zinc-substrate rather than a zinc-enzyme interaction. The 
binding constant for zinc to D-dimer was determined by Scatchard analysis 
of zinc titration data. The interaction of zinc and f-D-dimer was confirmed 
by fluorescence anisotropy determinations. The nature of the coordination 
capsule around the metal cation was determined by examining a cobalt-
-flbrtn-D-dimer complex and characterising the difference visible absorption 
spectrum thereof. The donor ligands from the D-dimer fragment for the 
l 
metal ion were determined as histidines by examining zinc(II) and cobalt(II) 
binding to diethylpyrocarbonate modified flbrin-D-dimer and hydroxylamine 
treated DEPC-flbrtn-D-dimer. 
Through this study it has been established that the PAV protease 
cleavage ~f the di-y-chain of the plasmin derived D-dimer fragment is 
potentiated by zinc(II) ions through the formation of a novel zinc determined 
conformation of flbrtn-D-dimer. This presents the possibility of a fibrin-
specific neo-epitope being manifested in the presence of zinc ions that could 
provide a means to determine fibrin degradation products more specifically. 
A model for the neo-epitope has been proposed. 
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1. INTRODUCTION 
The interaction of metal ions with proteins is an interesting 
consideration when contemplating the biology of evolution. The 
cooperative interaction of metal and protein results in a change in the 
conformation or the electrical state of the protein. These 
modifications in tum confer on the protein more efficient catalytic 
properties as an enzyme or result in a potentiation of the substrate. 
This thesis discusses the role of zinc(II) in the digestion of a plasmin 
derived fragment of polymerised fibrinogen by a snake venom 
protease. To this end the following points are discussed in the 
Introduction: 
1.1 Zinc protein interactions. 
1.2 Structure of fibrtnogen 
1.3 The polymerisation of fibrtnogen and flbrino(geno)lysis 
1.4 Fibrinogen and fibrin interactions 
1.5 Assaying the degradation products of fibrinogen and fibrin 
1.6 Snake venom enzymes and fibrtnogen 
The introductory discussion of each category now follows -
1.1. Zinc-Protein Interactions 
Zinc has been known as a biologically important metal for a long time. 
Adult human beings contain approximately 2g of zinc, most of which 
is bound to zinc enzymes and zinc proteins, and the free zinc 
concentration in plasma is low (Prince, 1979). The other two metals 
that share group IIB with zinc, ie. cadmium and mercury, have no 
known biological role and are among the most toxic of metals. What 
is it then about zinc chemistry that affords the metal its outstanding 
biological significance ? 
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Zinc has the electron configuration [Ar] 3d 10482 and therefore has a 
highly stable divalent state, [Ar] 3d 10, due to the completely filled 
outermost (d) shell compared with the higher oxidation states. This 
is important in a biological medium that has a dynamic oxidative 
potential in continual flux. 
Zinc is relatively inert with respect to oxidoreduction susceptibility 
that is characteristic of the other transition elements. Oxidoreduction 
is a major factor in changes in coordination geometry and in 
determining rates of ligand substitution. Zinc(II) tends to favour a 
tetrahedral geometry when bound to organic ligands, however, the 
coordination spheres of zinc complexes exhibit flexibility and 
stereochemical adaptability. Vallee and Auld (1990a) conclude that 
the multiplicity of geometry and coordination numbers denote that 
zinc readily submits to the demands of its ligands and these 
properties provide a mechanism for the translation of chemical 
structure into biological functions. 
Zinc, through coordination to biological molecules, may have a 
structural or catalytic role and even exhibit both functions. The zinc 
structures in biological systems may be broadly divided into three 
groups: 
1.1.1 The 'zinc fingers' - a conserved class of eukaryotlc nucleic binding 
proteins involved in the regulation of gene expression and 
specification of cell fate (Klug & Rhodes, 1987, Berg, 1986a,b); 
1.2.1 The zinc enzymes and 
1.3.1 The zinc proteins. 
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1.1.1 The 'Zinc-fingers' 
The last decade has seen an entirely new group of zinc proteins 
attracting a great deal of interest in the literature. An important part 
of gene expression and regulation is the binding of a regulatory 
protein to the recognition sequence of an appropriate gene. Such 
proteins would need to be structurally suited for binding to the DNA 
helix and therefore would have to contain a domain or motif to serve 
for such binding. Several bacterial proteins (regulatory) possess helix-
turn-helix motifs, as observed in their crystal structures, for this 
purpose (Klug & Rhodes, 1987). Eukaryotic systems solve this 
problem via the formation of 'zinc fingers' which provide the structural 
motif for binding to the DNA helix. The 'zinc fingers' are in fact 
peptide loops with a single zinc atom coordinated to two cystine and 
two histidine residues at the base forming a finger (Berg, 1986b). 
It has been suggested that since the redox state intracellularly does 
not favour cysteine disulphide bridges an alternative mechanism to 
stabilise peptide loop structures requires zinc coordination . 
There are two types of 'zinc fingers' corresponding to two models of 
interaction with the DNA helix (Fairall, 1986: Berg, 1988) . 
. 
The first model has the regulatory protein with its 'zinc fingers' 
following the helical path of the major groove with consecutive 'zinc 
fingers' equivalently orientated with respect to the DNA double 
stranded helix and so each repeat is one finger as is illustrated in 
Transcription factors IIIA and SpI (Fairall, 1986, Berg, 1988, 
Kuwahara, 1990, Frankel, 1987). 
In the second model, the regulatory nucleic acid binding protein lies 
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on one face of the double helix, alternate 'fingers' make non-
equivalent DNA contacts in accordance with a two finger repeat. 
Some illustrative examples are the 'zinc finger' motifs in human male-
associated protein ZFY (Weis et al, 1990), the Kruppel-related 
sequence in Xenopus laevis (Nietfield et al, 1989) and the human 
DNA-binding nucleocaspid protein that recognises the HN-I enhanced 
sequence (South et al 1990). The latter finding may have dynamic 
implications in the long road to the development of vaccines for the 
prevention of AIDS. 
1.1.2 The Zinc Enzymes 
The,first metalloenzyme to be discovered (1940) was carbonic 
. 
anhydrase (EC 4.2.1.1) which catalyses the reaction 
to complete the transfer of carbon dioxide from the tissues into the 
blood and finally into the alveolor air. The enzyme catalyses the 
reaction 106-fold. The zinc cation in carbonic anhydrase is contained 
in a deep protein pocket which also contains water molecules 
arranged in an ice like order. Zinc is coordinated to three imidazole E 
nitrogens and an 'activated' H20 molecule (Vallee & Auld, 1990b). It 
seems possible that the coordinated H20 molecule converts zinc to 
zincate Zn(OH)+, the zinc ion donates a hydroxide ligand to carbon 
dioxide, which is attracted to the hydrophobic cavity on the enzyme. 
The nucleophilic hydroxide interacts with the carbon dioxide to form 
the bicarbonate ion. This is equivalent to replacing the 106 slower 
uncatalysed reaction. 
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Only the forward reaction is favoured at high pHs. The enzyme with 
its zinc plays a Lewis base role allows the conversion to occur at 
physiological pH (Fisher, 1975). 
The other traditionally cited zinc enzyme is carboxypeptidase A (EC 
3.4.17.1), a digestive protease that hydrolyses the carboxyterminal 
peptide bond in polypeptide chains. The enzyme coordinates zinc 
through the imidazole rings of two histidines, the side chain of one 
glutamic acid and one 'activated' water molecule (Blow & Steitz, 
1970). The enzyme's zinc together with other groups at the active site 
induce rearrangements in the electronic distribution of the substrate, 
thereby rendering it more susceptible to hydrolysis. 
Vallee and Auld ( 1990a) on examin.~tion of the sequences of twelve 
zinc enzymes whose crystal structures are known deduce that 
catalytic zinc cations coordinate with the enzyme through three amino 
acids, cysteine, histidine or glutamic acid, and one 'activated' water 
molecule. The structural zinc atoms seem to coordinate almost 
exclusively to cysteine residues through the sulphur atoms. An 
example is the class I enzyme alcohol dehydrogenase (EC 1. 1. 1. 1) 
whose structural zinc atom is tetrahedrally bound to the four sulphur 
atoms of C-97, C-100, C-103 and C-111. The functional or active-site 
zinc has to co-operate with the coenzyme NADH. This catalytic zinc is 
coordinated to two cysteine residues, one histidine and one water 
molecule (Eklund & Branden, 1983). 
Aspartate transcarbamyolase, a class II enzyme (EC 2 . 1.3.2) 
possesses a single structural zinc coordinated to C-109, C-114, C- 137 
and C-140 in a tetrahedral fashion where the zinc holds together two 
loops formed in this region of the polypeptide chain which forms part 
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of the interface between the regulatory and catalytic subunits, the 
zinc stabilisation of the loops is thought to be responsible for 
stabilising the quaternary structure. There exists a strong likelihood 
that the zinc induced local conformational and structural change 
lends itself to the fine tuning of its interaction with the catalytic 
subunit due to the entropic contribution to the energy of activation of 
zinc binding at such sites (Keating, 1985 ). Recent work on the 
enzyme has focussed on an examination of Zinc(II) interactions with 
ATCase and with the isolated regulatory subunits of ATCase with a 
view to gaming information on the structural roles of zinc in the 
intact enzyme and in the assembly of the enzyme (Jefferson et al, 
1990). 
The class III hydrolases consist of the metallo exo- and endo-
peptidases. A notable example of a metalloendopeptidase, 
thermolysin (EC 3.4.24.4) contains one catalytic zinc liganded to H-
142, H-146 and E-166 and a distorted tetrahedron is completed by a 
water molecule, in addition to several structural calcium atoms 
(Monzingo & Matthews, 1982). A representative example of a class IV 
enzyme that coordinates zinc is 5-aminolevulinate dehydratase 
(Dent et al, 1990). 
1. 1.3 The Zinc Proteins 
Zinc is also structurally bound to a variety of non-enzyme proteins. 
The most abundant zinc protein in plasma is albumin (Failla et al, 
1982, Parisi & Vallee, 1970). Albumin binds zinc(II) with a 
dissociation constant of pK = 6.98, binding sites n = 1 (Marx, 1988). 
The iron transport protein transferrin can transport zinc in the 
absence of iron. The equilibrium constants for zinc(II) binding to the 
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two available binding sites have been determined at pK 1 = 7 .8 and 
pK2 = 6.4, K 1 corresponds to zinc binding the C-terminal site and K2 
for the 
N-terminal site at pH 7 .4. These results indicate that at serum 
bicarbonate concen~rations, transferrin should have a higher affinity 
for zinc(II) than serum albumin indicating a possible role in zinc 
transport (Harris, 1983). 
Zinc has been shown to play an interesting structural role in the 
ollgomerisation of human growth hormone (hGH) to hGH dimers. The 
dimer binds two zinc atoms per dimer molecule in a cooperative 
fashion with each zinc liganding in a tetrahedral configuration to 
H-18, H-21 and E-174 bridging two hGH molecules into a more stable 
hGH dimer which has been proposed as the major storage form of the 
protein (Cunningham et al, 199 la, b, c). 
1. 1.4 Zinc and Fibrinogen and Fibrin 
Marx ( 1988) studied the non-specific binding of zinc to fibrinogen and 
the zinc content of 'collapsed' fibrin gel supernatant by means of 
ultrafiltration and atomic absorption techniques. Essentially, the 
linear polymerisation of fibrin monomers into protofibrils is not a 
cation sensitive process, however. calcium(II) and zinc(II) 
independently of each other are both capable of inducing the 
formation of gel by augmenting the lateral association of the 
protofibrtls . The gelation is modulated by physiologic levels of 
calcium(II) and zinc(II). Marx calculated that zinc binds to fibrinogen 
with dissociation constant K0 = 18µM ±. 3µM and n = 6. It is also 
important to note that zinc(II) does not compete with calcium (II) for 
binding to fibrin . 
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Scully & Kakkar ( 1982) reported the adsorption of flbrinogen to zinc 
chelate colums at pH 7.8. The flbrinogen eluted sharply with a pKa of 
5.8. Although the binding was (highly) non-specific, the pKa of 5.8 
implies the involvement of histidine residues. 
1.1.5 Zinc as a Micronutrient 
Zinc was first shown to be an essential trace element in living systems 
'• 
as early as 1869, when Ranlin showed the trace element as a basic 
nutrient for Apergillus niger. Zinc distribution in biological fluids and 
tissues has been studied in detail by various groups (Fisher, 1975). 
The total zinc concentration in human beings is approximately 
2.0g/70kg (Underwood, 1971). This is about half that of iron and 10-
15 times that of copper. Zinc is not distributed uniformly in the body. 
Those tissues with high zinc concentrations include the prostrate, 
skin and appendages, choroid, liver, pancreas, bone and blood. Zinc 
is found in high concentrations in keratins with 20% of the total body 
zinc in the skin (Fisher, 1975, Underwood, 1971). 
Zinc in human blood is distributed 75-88% in erythrocytes, 12-22% in 
plasma and 3% in leukocytes. The normal plasma content of zinc in 
healthy individuals is within the range 10.7-16.9 µM (Failla et al, 
1982). Serum zinc is higher than plasma levels by about 16%. This 
is due primarily to the platelet disintegration during clotting and the 
greater dilution in plasma. Hemolysis contributes 4% to the serum-
plasma difference. Plasma zinc is bound approximately one third to 
albumin and 35% to a-macroglobulin (Parisi & Vallee, 1970). 
Research in the last decade has implicated serum transferrtn as a 
possible major zinc transporter as well (Harris, 1983, Chesters & 
Wile, 1981). 
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1.2. Structure of Fibrtnogen 
Fibrtnogen crystallisation has proved to be difficult enough to the 
extent of there being no X-ray structure available at this time. In the 
absence of such data, a low resolution model for the structure of 
:flbrtnogen has had to be postulated from electron microscopy and 
chemical studies. The fibrtnogen molecule, Mr 340 000 is dimertc, 
each monomer consisting of three non-identical but genetically-
related polypeptide chains designated Aa, B~ and y. The molecule is 
arranged in a trinodular structure (Hall & Slayter, 1959, Doolittle, 
1975, Doolittle, 1984). The central region, the E domain - also called 
the N-terminal disulphide knot (NDSK) - is dimertc containing the 
amino terminals of all six constituent chains. The two sets of chains 
extend away from the E domain to end in two carboxyterminal 
domains designated the D-domains, thus the trinodular structure 
(Fig. l ). The three chains form three-stranded ropes arranged in coiled 
coils between the D-domains and the central E-domain and are joined 
together by a series of disulphide linkages (Hoeprich and Doolittle, 
1983) (Fig.2). In the N-terminal disulphide knot, the two halves of the 
molecule are linked by three disulphide bonds, one between the two 
a-~hains (residue a-28) and two between they-chains (residues y-8 & 
9) (Hoeprtch & Doolittle, 1983). The human flbrtnogen molecule has 
29 disulphide bonds of which 11 are found in the central domain 
(Hoeprtch & Doolittle, 1983, Doolittle, 1984) 
11 
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Figure 1: Schematic drawing of flbrinogen. The central region is the N-
terminal disulphide knot (NDSK). This is joined to the two distal D-
domains by connecting coiled coils. The flbrinopeptides FPA and FPB 
are shown. (Doolittle, 1984) 
12 
Figure 2: The schematic depiction of the 29 disulphide bonds in human 
flbrtnogen of which 11 are found in the central domain. 
(Doolittle, 1984). 
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Fibrinogen is a glycoprotein with the carbohydrate moieties located on 
the B~- and y-chains while the Aa-chains do not contain carbohydrate 
(Gaffney, 1972, Pepper et al. 1974). An examination of the synthesis 
of fibrtnogen reveals that the a-chain receives its core carbohydrate 
early as a cotranslational event. The B~-chain is glycosylated later, 
possibly at the time of polypeptide termination or shortly before 
release from the ribosome into the cistemal space of the rough ER 
(Nickerson & Fuller, 1981). The sialic acid residues of the 
carbohydrate moiety have been shown to be low affinity sites whose 
occupancy by ca2+ and physiological calcium concentration may 
facilitate fibrin polymerisation (Dang et al, 1989). 
1.2.1 The amino acid sequence of flbrtnogen 
The quest for the complete amino acid sequence of flbrtnogen 
dominated flbrinogen research in the 1970's (Okude & Iwanaga, 1971, 
Sharp et al. 1972, Takagi & Doolittle, 1975, Lottspiech & Henschen, 
1977, Doolittle et al, 1977a,b,c, 1979a;b). The completed amino acid 
sequence as per Henschen (1983) is shown in figure 3. 
1.2.2 The Gamma Chain 
The y-chains of human flbrinogen are 411 amino acids long and are 
primarily important in coagulation as being the location of 
polymerisation sites (Olexa & Budzynski, 1981) as well as the site for 
the Factor XIIIa induced crosslinking (Chen & Doolittle, 1970) and the 
ca2+ 
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161 I PT NL RV LR S I LEN LR SK (· Q KL ES D VS A QM E Y CRT PCT VS 
201 C N I P V VS GK EC EE I R KG GETS EM Y LIQ POSS V KP YR VY C 
Z41 0 MN TENG G ~TV IQ N R Q O GS VO F GR KW OP Y K Q G F G NV AT NT 
281 D GK NYC G LPG E Y w LG NO KI SQ LT RM GP TELL I EM E OW KG D 
321 KV KAH Y G G FT V Q NE AN KY QI S V N KY R GT AGNA L MOGA SQ L 
361 MG E N+R TM TI H NG MF F STY DR D NO G W LT SOP R K QC SK EOG G 
401 G WW Y N RC HAAN P NG RY Y W G G q YT W D MAK HGT O O G V V W H NW 
441 KG SW Y SM R KM SM KI RP FF P Q Q 
Y V A T R O N C C I L O E R F G S Y C P T T C G I A O F L S T Y Q T K V D K D L 
4\ Q SLED I L HQ VE N+K TSE V K Q LI KA IQ LT Y NP DESS KPN HI 0 
81 A AT L KS R KM LEE IM KYE AS I ~ T ~ 0 S S I RY L Q E I Y NS N N Q K 
121 IV NL KE KV A Q LE A QC Q E PC K D TV Q I HO I T GK O C Q O I AN KG 
161 AK~ S G LY FI KP L KAN Q Q FL VY CE I O GS G NG WT VF Q KR L D G 
201 S VO F K KN WI Q Y KEG F G ~LS PT GT TE F W LG NE K I H LI ST Q S 
Z41 A IP YA LR VELE OWN GR TS TAO YAM F KV GP EA OK y R LT y A Y 
Z8l FAGG O AG DA FD G FD Fr, DO PS OK FF TS H NG M Q F ST WON OH D 
321 K FE G NC A E OD G(S)G w(w)n N KC~ AG~ LNG Vy y Q G GT y SK AST p 
36 l N G Y O N G I I (w)A T(w)I( T R W Y S M K K T T M K I I P F N R L T I G E G Q Q H 
401 H LG GA K q AGO V 
Figure 3: The complete amino acid sequences in human fibrinogen Aa-, B~-
and y-chains. The arrows indicate the sites of thrombin 
cleavage resulting in the removal of FPA and FPB, and+ 
indicate the carbohydrate side chains. (Henschen et al, 1983). 
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binding sites (Varadi & Scheraga, 1986). The human flbrinogen 
y-chain is heterogenous with respect to charge, sialic acid content and 
molecular weight (Wolfenstein-Todel & Mossesson 1980, 1981). Three 
forms of flbrinogen y-chains have been purified from normal human 
plasma (Francis et al, 1984, 1988). 
1.3. The polymerisation of Fibrinogen and Fibrino(geno)lysis 
1.3.1 Polymerisation of Fibrtnogen to Fibrin Gels 
The formation of a blood clot begins with the triggering of the blood 
clotting cascade that is a step-wise sequential system of activation of 
proenzymes to their active enzyme forms that in tum activate the next 
proenzyme. The cascade may be triggered by extrinsic or intrinsic 
factors. Both pathways converge to activate prothrombin to thrombin 
which in tum converts flbrinogen to fibrin in the presence of ca2+ 
ions. 
Thrbmbin removes a pair of (hexadeca)peptides, flbrinopeptide A 
(FPA), from the amino terminus of the Aa-chain of flbrinogen 
(Hoeprich & Doolittle, 1983). This exposes an association site 'A' in 
the amino terminal region. This site binds specifically to the 
corresponding site always available in the carboxy terminal region of 
(the D-domain), the 'a' site (Kudryk et al, 1974). This association 
proceeds in an end to end fashion with half staggered overlaps 
resulting in the formation of linear protofibrils. This is the beginning 
of a loose clot. After formation of some protoflbrtls, flbrtnopeptides 
(FPB) are removed from the amino terminals of the Bl3-chains. This 
reveals another site of association in the aminoterminal region called 
site· 'B' (Blomback et al, 1978). The removal of FPB results in a tight 
aggregation of flbrinogen that progressively 
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Figure 4: A schematic representation of the sequence of events in fibrin 
formation. The possible interactions at the polymerisation sites 
A:a and B: b are schematically shown. The dimertc nature of 
fibrtnogen dictate that each of these sites are present in 
duplicate ie. AA 1 etc. The lower part of the figure summarises 
the events occuring during the formation of the two types of 
fibrin, I and II. 
(Blomback et al, 1978). 
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blocks a concomitant release of FPA when treated with copperhead 
snake venom below 25°c (Shainoff & Dardik, 1979). 
The end to. end association in the protoflbrils aligns the 
carboxyterminal domains of the adjacent molecules and creates a new 
association site, site 'b' (Olexa et al, 1980, 1981 ). This alignment is 
stabilised by the formation of Factor XIII induced crosslinks 
(described later) (Lorand, 1980). Sites Band b then make specific 
and complementary lateral associations that allow the protoflbrils to 
grow laterally. This completes the formation of a clot that is both 
mechanically rigid as well as resistant to lysis. 
1.3.2 Location of the Polymerisation sites 
... 
Fibrtnogen exists as a trinodular unit and therefore a half staggered 
orientation for polymerisation resulting from the interaction of the 
central E knot domain with the distal carboxy terminal domains 
would seem a logical one (Heene & Matthias, 1973, Olexa & 
Budzynski, 1980, Smith, 1980). The development of a model for the 
mechanism of fibrin polymerisation resulted from an examination of 
the binding between flbrinogen, fibrin and their degradation products 
(Kudryk et al, 1974, Blomback et al, 1978, Olexa et al, 1980, 1981, 
Horwitz et al, 1984). 
Olexa ( 1980) reported evidence for four different polymerisation sites 
on human flbrinogen. Two of the sites 'A' and 'B' are located in the 
N-terminal domain and become exposed with thrombin cleavage of the 
flbrinopeptides FPA and FPB. The other two sites 'a' and 'b' are 
thrombin independent. The sites 'a' and 'b' are distinguishable as 'a' 
occurs in the 
18 
Thrombin 
Fibrinogen Fibrin monomer 
Linear fibrin polymer 
H 
Lateral fibrin polymer 
Figure 5: The model for fibrin polymerisation. The flbrinogen is depicted as a 
flexible banana model. The interaction of the polymerisation 
sites are shown. (Olexa & Budzynski, 1980). 
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carbo:xy-terrninal region of fragment D while the 'b' site only becomes 
available in the C-terrninal region of aligned fibrin-D-dimer. One 
polymerisation site was localised at the C-terrninal domain of 
fibrinogen within they-chain between amino acids 303-411 (Olexa & 
Budzynski, 1981, Southan et al, 1985, Varadi & Scheragen, 1986). 
The location of the y-chain crosslink acceptor site is on the y-chain 
carbo:xy terminal end (Fretto et al, 1978, Holm et al, 1985). 
Polymerisation inhibition studies with synthesized short peptides 
corresponding to the amino termini sequences of the a-and p-chains 
showed that peptides based on the sequence Gly-Pro-Arg from the 
a-chain were effective inhibitors of fibrin polymerisation (Doolittle & 
Laudano, 1980, Laudano et al, 1983, Doolittle, 1984, Furlan, 1982). 
Thus, a primary polymerisation site complementary to that located in 
the C-terrninus of fragment D, site 'a' is present in the N-terrninus of 
the fibrin a-chain. Another inference of the synthetic peptide study 
was that the polymerisation in those systems is driven by the G-H-R 
knobs combining with complementary 'holes' ordinarily occupied by 
G-P-R 'knobs' (Doolittle, 1984). The maintenance of native 
conformation is essential for the expression of polymerisation site 'b' 
with the portion of the fibrinogen molecule present in the high 
molecular weight fraction but not in the low molecular weight 
fraction. The BP-chain His-16 which lies only one residue away from 
the thrombin susceptible bond was shown to be essential for 
polymerisation site A leading to end-to-end association of fibrinogen 
upon the release of FPA (Shimizu et al, 1986). The most recent 
contribution to the polymerisation site saga is that the fibrin 
polymerisation site in the N-terrninal domain of fibrin may be 
composed of sequence derived from both the a- and p-chains (Pandya 
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et al, 1991) 
1.3.3 The Transglutaminases 
The transglutaminases are the enzymes that catalyse the formation of 
e(y-glutamyl)-lysine bonds between the y-carboxy group of a glutamine 
residue on one polypeptide chain and the e-amino group of a lysine 
residue side chain on another with the loss of ammonia. This is the 
result of a Ca(II) dependent acyl transfer reaction (Lorand et al, 1980). 
This class of enzyme is widely distributed in the various tissues and 
body fluids. Each has distinctive physical properties and distribution 
in the body (Ichinose et al, 1990). The transglutaminase that is of 
particular importance to this study is the plasma enzyme that 
completes the formation of the fibrin clot by inducing E(y-glutamyl) 
lysine crosslinks between the antiJ)~rallel di-y-chains (Chen & 
Doolittle, 1970) as well as the a-chains of fibrin of the long protofibrils 
to form a solidly meshed clot. This enzyme is Factor XIIIa of the 
coagulation cascade. 
1.3.3.1 Human Factor XIII: Fibrin Stabilising Factor: Laki-Lorand 
Factor 
Factor XIII is a glycoprotein that circulates in the blood as a 
proenzyme. During the final step of the blood coagulation cascade, 
the proenzyme is activated to Factor XIIIa by thrombin in the 
presence of calcium ions that then catalyses the polymerisation of 
fibrin monomers into a tightly crosslinked rigid clot which now has 
increased resistance to lysis (Lorand et al, 1980, Ichinose et al, 
1986). Clots formed in the absence of Factor XIIIa, eg. in genetically 
determined deficiency, are dissociable in 4M urea (See Addendum 
N). Factor XIII is a tetramer of two pairs of dimertsed subunits a2b2 
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with a total molecular weight of 320 000 daltons. The two catalytic a 
subunits are 75 000 daltons each and the two non-catalytic b 
subunits are 80 000 daltons each (Schwartz et al, 1973). 
The active enzyme (Factor XIIIa) is generated during the final stages 
of the blood coagulation cascade by the release of the activation 
peptide which is 4000 daltons from the amino terminus of each of 
the catalytic a subunits. Subsequent to this proteolytic event, a 
series of ca2+ dependent reactions occur. 
activation 
peptide 
* 
a2 
The tetramer dissociates into an active dimer (a12 ) and releases the 
two non-catalytic subunits. The a'2 ensemble undergoes a 
conformational change by binding calcium ions thus unmasking the 
* active-centre thiol group in the final active form (a 2) - 1.e.(Factor 
XIIIa) (Lorand et al, 1981, Lewis et al, 1985, Ichinose, 1990). 
Non-crosslinked polymeric fibrins I & II (polymerised des-A and 
des-A,B-flbrinogens were shown by Lewis et al (1985) to be powerful 
promoters of the thrombin catalysed release of the activation peptide 
from a2b2. This occurs through the formation of a complex between 
the non-crosslinked polymer with FXIII. The complex has a higher 
affinity for thrombin than does free Factor XIII. In addition the 
system has a negative feedback system of regulation as the 
enhancement of the active peptide release decreases dramatically as 
the product of activation, Factor XIIIa, catalyses the crosslinking of 
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the fibrin substrates (Lewis et al, 1985). 
1.3.3.2 The Factor Xllla Catalysed crosslinking of Fibrin 
The thrombin activated Factor Xllla catalyses the fusion of fibrin 
units producing y-glutamyl-E-lysine site chain bridges 
intermolecularly (Lorand et al 1981 ). This crosslinking occurs 
between the carboxy terminal regions of antiparallel y-chains of 
fibrin (Chen & Doolittle, 1970) and the sites on the a-chain that are 
highly susceptible to proteases. 
( 
+ ffwN~(Fibrin) 
0 
j 
II c . . .. 
(Flbrin)~C, ~(Fibrin) 
,. u + NH,. 
These two isopeptidic crosslinks result in the formation of a di-y-chain 
linking adjacent D-domains. The assignment of the sites of crosslink 
remain as a matter of some controversy. While it has been 
demonstrated unequivocally that K-406 is the acyl acceptor, either of 
two Q residues are the putative acyl donor. These are the adjacent 
glutamines Q-398 or Q-399. The latter seems to be the dominant site 
accounting for more than 80% of the crosslinks (Purves et al , 1987) 
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1.3.3.3 The Factor XIII Gene 
The Factor XIII b subunit encoding gene (Fl3B) was found to be on 
chromosome lq3 l-32. l (Webb et al, 1985) and the gene coding for 
the Factor XIII a subunit (Fl3A) was localised to chromosome 
6p24...25 (Board et al, 1988). The Fl3A gene contains 15 exons with 
a total of 3905 bases (Cundmann et al, 1986). The exon 15 is the 
largest and codes for the carboxy terminus of the protein and the 3' 
non-coding region of the gene. The entire activation peptide (amino 
acids 1-37) is encoded by exon 2 . The active site Cys-314 region is 
encoded by exon 7. The thrombin cleavage site (between K-513 and 
S-514) that leads to inactivation is encoded for on exon 12. The two 
putative calcium-binding sites are encoded by exon 6 and 11 
respectively. It would appear that_ the intrans separate the gene into 
the functional and structural domains (Ichinose & Davie, 1988 ). 
The b subunit amino acid sequence has. been determined by cDNA 
cloning and amino acid sequencing. Each of the non-catalytic 
subunits consists of 641 amino acids (Ichinose et al, 1986). The b 
subunit contains 10 tandem repeats of 60 amino acids known as 
GP-1 structures, short consensus repeats (SCR). or sushi domains 
(Bottenus, 1990). The sushi structures have characteristic 
disulphide bonds between the first arid third and second and fourth 
cysteines (Ichinose et al, 1990). 
The Fl3B gene is 28 kilobases in length consisting of 12 exons. The 
exons range from 64 to 222 bases in length while the introns range 
in size from 87 to 9970 bases. Each sushi domain was found to be 
encoded for by a single exon. The internal homologies of the sushi 
. 
domains at the DNA level range from 36% to 43% (Bottenus et al, 
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1990). Many of the genes coding for multiple sushi domains on 
other protein eg. those in the complement receptor types 1 and 2, 
Factor H, decay accelerating factor (DAF) and the a subunit of C4 
binding protein are also located at chromosome lq32 (Webb et al, 
1989). 
1.3.3.4 Other Transglutaminases 
There are four other transglutaminases present in the human body. 
They are a) the tissue transglutaminase found in the cell cytosol of 
all tissues and organs: b) epidermal transglutaminase; c) hair 
follicle transglutaminase: and d) prostrate transglutaminase (Chang 
& Chang, 1986, Davies et al, 1985, Fesus et al, 1987). 
1.3.4 Calcium and Fibrin(ogen) 
Calcium has been shown to play an important role in all stages of the 
clotting process. This interaction begins with the activation of 
thrombin - a calcium dependent reaction. The divalent cation has 
be.en shown to greatly accelerate the polymerisation of fibrin and 
decrease clotting time significantly (Boyer et al, 1972, Endres & 
Scheraga, 1972, Kanaide et al, 1982, Alkjaersig & Fletcher, 1983, 
Furlam et al, 1982). Alkjaersig & Fletcher ( 1973) report that in the 
presence of ca2+, during polymerisation, additional binding sites 
appear to play a role, since dimer formation was now superceded by 
the formation of higher oligomers. Laudano and Doolittle ( 1983) on 
an examination of the effect of ca2+ on the binding of various 
peptides to flbrinogen found the influence of the divalent cation to be 
predominantly on the G-H-R-P (P-chain type) binding site. Calcium 
was found to increase site accessibility. 
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Calcium is also required for the thrombin dependent activation of 
coagulation Factor XIII (Greenberg, 1985, Lewis et al, 1978). 
Fibrinogen has three high affinity calcium specific binding sites 
(Marguerie-et al, 1977). Two of the 3 sites on human fibrinogen are 
located in the D-domains (Lindsey et al, 1978b). The two sites are 
equivalent with identical binding constants (log k = 5.045) (Lindsey et 
al, 1978b). Recent data indicates that the D-domain calcium binding 
site is located on the y-chain segment of y-303-355 / 356 (Dang et al, 
1985, Varadi and Scheraga, 1986). The presence of calcium ions 
increase the surface area of fibrinogen, due mainly to the C-terminal 
regions of Aa-chains moving from an inward orientation to a more 
solvent exposed position. This conformational change leads to the 
molecule being more prone to form _intermolecular associations due to 
the exposure of those sequences important for interaction. These 
effects are mediated through binding to low-affinity calcium sites on 
the molecule (Apap-Bologna et al, 1989). 
1.3.5 Fibrino(geno)lysis 
In,_travascular fibrin clots that are due either to a response to vascular 
injury or thrombosis needs to be removed to restore free flow of blood 
through the vessels. This is achieved through the fibrinolytic 
pathway. The solid fibrin deposits are degraded to soluble complexes 
by the serine protease plasmin that is activated from the zymogen 
plasminogen through the action of plasminogen activators. These 
serine proteases catalyses the hydrolysis of the Arg-561-Val-562 bond 
in plasminogen (Fears, 1989). Due to the restricted substrate 
specificity of plasmin, mechanisms to localise 
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Figure 6: A schematic representation of tissue plasmtnogen activator (t-PA). 
The figure emphasises A-chain domains:fibronectin-like finger 
(F), epidermal growth factor-like sequence (G). Krtngles I and 2 
(K 1,K2). The plasmin-cleavage site is indicated by A 
. (Fears, 1989). 
27 
0 
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Figure 7: A schematic portrayal of a trimolecular complex formed between 
t-PA, plasminogen and fibrin. The Kringle K 1 of plasminogen 
interacts with the E-domain of fibrin and K5 with the 
D-domain. The plasminogen in turn, interacts with the active 
site of the t-PA. (Takada et al, 1990). 
the generation of plasmin and confine its action to the site of the clot 
are required (Norrman et al, 1985). There are two recognised 
mechanisms: 
a) Tissue plasminogen activator (tPA) is efficient only in the presence of 
fibrin (Fears, 1989, Norrman et al, 1985, Takada et al, 1990, Varadi & 
Pathy, 1983, Higgins & Vehar, 1987). In the absence of fibrin the tPA 
activation of plasminogen decreases 1000-fold (Ran by, 1982), 
b) the plasmin generated but not engaged in fibrin degradation is rapidly 
inhibited by the a 2-plasmin inhibitor (Wiman & Collen, 1978, Sakata 
& Aoki, 1982). 
Fibrin acts as both substrate and cofactor contributing to the 
.. 
increased plasmin production by forming a ternary complex with 
plasminogen and the tissue type plasminogen activator (Fears, 1989, 
Higgins & Vehar, 1987). The plasminogen binding sites thought to 
be in the D-fragment are controlled by the carboxy terminal of the 
y-chain (Varadi & Patthy, 1983, Lucas et al, 1983a,b) while the kringle 
2 domain of tPA is implicated in the binding of the activator to fibrin 
(Larsan et al, 1988, Wojta et al, 1989}'. Fibrin also interacts with a 
second endogenous activator, the single chain urokinase-type 
plasminogen activator (Fears, 1989, Takada et al, 1990, 
Lucas et al, 1983). 
1.3.6 Plasmin digestion of fibrinogen 
The subunit chains of fibrinogen differ in their susceptibility to 
plasmin digestion. The order of susceptibility is a > ~ > y (Pizzo et al, 
1972, Gaffney & Dobos, 1971). Plasmin digestion leads to the 
formation of 
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Figure 8: The effect of plasmin on fibrinogen. A schematic representation of 
the sequential reactions that occur during the plasmin digestion 
of human fibrinogen. The final product of the digestion are 
fragment E (Mr 41 000) and fragment D (Mr 83 000). (Pizzo et al 
1972). 
fragments X and Y together with the associated low molecular weight 
products. These fragments are further digested to finally yield 
fragment D (Fig.8). Further digestion occurs in the absence of 
calcium ions but this is not physiologically relevant (Purves et al, 
1980). Digestion begins with hydrolysis at the carboxyterminal of the 
Aa-chain concomitant with the appearance of fragment X releasing 
fragments A, B & C. This is followed by an initial release of a small 
portion of the ~-chain at the amino terminus (Mossesson et al, 1972, 
Pizzo et al, 1972, Budzynski et al, 1974). Each cleavage exposed 
further plasmin susceptible sites in a cooperative manner. N-terminal 
digestion on all three chains releases the D-fragment to yield fragment 
Y and the release of the second D-fragment yields fragment E. Thus 
the final products of plasmin diges~ion of flbrinogen are the fragments 
D and E and low molecular weight peptides from each chain (Pizzo et 
al, 1972, Mossesson et al, 1972, Lucas et al, 1983). 
1.3. 7 The Plasmin degradation of crosslinked fibrin 
The plasmin digestion of a fibrin gel presents a more complex pattern 
due to the complicated polymerised structure reinforced with Factor 
XIIIa induced crosslinks between they-chains (Lorand et al, 1980). 
Francis and Marder ( 1982) developed a model for the complete 
plasmic digestion of crosslinked fibrin. The degradation has been 
divided into four distinctive phases: 
Phase 1 involves an initial limited proteolysis without interfering with 
the covalent attachment of the D and E domains to the other parts of 
the matrix. This phase is characterised by the extensive cleavage of 
the a polymer chains. 
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Figure 9: The effect of plasmin on fibrin. A schematic diagram of a four-unit 
fibrin polymer joined by Factor XIIIa catalysed crosslinks, 
indicating the principal cleavage sites for plasmin and the 
fragments resulting their from. The final products of plasmin 
digestion are fibrin are the E fragment and the D-dimer 
fragment. (Francis & Marder, 1982). 
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Phase 2 denotes the degradation of fibrin to the extent of all 
degradation products are still attached to the matrix but now via non-
covalent linkages. 
Phase 3 involves the release of the soluble complex into solution. 
Phase 4 describes the degradation of soluble complexes subsequent to 
release from the matrix. 
• Figure 9 illustrates the progressive plasmic degradation of crosslinked 
fibrin indicating both the points of cleavage and the composition of 
the resulting degradation products. The soluble crosslinked 
degradation products are DD/E, DY /YD, YY /DXD and XX:0/DXY. 
Upon release into solution these fragments are further digested by 
.. 
plasmin to release as final plasmic products fragments E and D-dimer 
(Frances & Marder, 1982, 1983). 
1.3.8 Calcium and Fibrinolysis 
In the presence of calcium (II) the final product of fibrinogenolysis is 
the fragment D(cate). Mr 93 000, which is protected from further 
plasminolysis by calcium. The absence of ca2+ results in the further 
plasmin digestion of fragment D to a smaller D-fragment (Mr 80 000) 
by breakdown of they-chain (Purves et al, 1978, Haverkate and 
Timan, 1977). The smaller D-fragment displays more crosslinking 
intermolecularly with chemical crosslinking agents suggesting the loss 
of the y-chain remnant results in a more open conformation, in the 
case of D(cate). however, the cleavage of more plasmin susceptible 
bonds is protected against by the presence of calcium ions (Britton et 
al, 1982). 
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The final product of fibrtnolysis, fragment D-dimer, is plasmin 
resistant by virtue of calcium ions (Haverkate & Timan, 1977, Purves 
& Lindsey, 1978a,b, Lindsey et al, 1978, Purves et al, 1980). The 
chelation of calcium ions unmasks plasmin susceptible sites (Purves 
et al, 1978). The plasmin digestion of fibrin in the absence of calcium 
results in the formation of a non-covalently linked D-dimer fragment 
(NCDD), the crosslink fragment is attached to the two D-domains 
electrostatically through non-covalent associations (Lindsey et al 
1978, Purves et al, 1980). While tightly bound to the parent 
molecules at higher temperatures, the crosslink peptide could be lost 
below 15°c (Purves et al, 1980). 
1.4 Fibrinogen & Fibrin Interactions 
The two important macromolecular interactions of fibrinogen and 
fibrin discussed thus far are the binding of thrombin to fibrinogen 
' (J&kubowski & Owen, 1989) initiating clot formation and interaction 
with plasminogen initiating the fibrinolytic pathways (Bok & Mangel, 
1985 ). Additionally, there are three major and several minor 
fibrinogen interactions of physiological relevance. 
An important macromolecular interaction of fibrinogen is that with 
fibronectin. Fibronectin is a 'molecular glue' (McDonagh, 1981) found 
in an extrinsic membrane form in connective tissues and basement 
membranes and in a soluble liver-produced form in plasma produced 
by a different transcript of the gene (Mosher, 1980, Pearlstein et al, 
1980, Purves et al, 1984). Fibronectin interacts, in addition to 
fibrinogen, with collagen, sulfated proteoglycans, gangliosides & 
bacterial cell wall 
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Figure 10: The possible interaction of :fibronectin and fibrin . The 
polymerisation of fibrin may bring the carboxyl portions of the 
a-chains together and allow the dimeric fibrinectin molecule 
(F) to bind at two sites rather than one. The disulphide linkage 
between F and Fl are indicated. (Mosher, 1980). 
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Figure 11: The proposed model of interaction between human flbrtnogen 
and human platelets. The hatched boxes represents 
carbohydrates on the P- and y-chains of flbrinogen. The 
platelet receptor recognition domains are marked as black dots 
encompassing sequences 95-98 and 572-575 on the a-chain 
and sequence 400-411 on the y-chain. One molecule of 
flbrinogen can be engaged in cis and trans interaction with 
platelet receptors. (Hawiger et al, 1989). 
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components implying functions as an adhesive and opsonic 
glycoprotein (Mosher, 1980). The role of plasma flbronectin as an 
opsonin, however, is not clear at all (Purves et al, 1984). 
In the presence of thrombin activated Factor Xllla, flbronectin is 
incorporated lmol/340 K.Da unit weight of fibrin. This leads to an 
increase in the gel turbidity and the permeability coefficient 
suggesting that the width of the strands of the gel increases as a 
result of flbronectin incorporation ( Okada et al, 1985 ). The secondary 
and tertiary structure of flbronectin is essential to binding (Isaacs et 
al, 1989). Binding to Factor XIII occurs in the absence of ca2+, 
suggesting that a domain on the transglutaminase other than the 
catalytic site is needed to complex with flbronectin (Turner & Lorand, 
1989). 
Fibrinogen binds to activated platelets and may have a fundamental 
role in the process underlying platelet aggregation. This binding 
occurs according to the law of mass action possibly dependent on 
allosteric modulation of the platelet receptor on binding a flbrinogen 
molecule (De Cristofaro, 1988). Platelet receptor sites of interaction 
have been localised on flbrinogen y-chains (Kloczewiak et al 1982a, 
1984, 1989) and a-chain (Hawiger et al, 1982, 1989). They-chain 
receptor recognition site is located between y-400 and y-411 
(Kloczewiak, 1984) and the a-chain site is in the amino terminal 
region (Hawiger et al , 1989) (Fig.11). The binding is ca2+ dependent 
(Phillips & Baugham, 1983 ). 
Human flbrinogen interacts with the cell wall component of certain 
staphylococci inducing clumping. An average of 2130 flbrinogen 
molecules bind per bacterial cell with Kn = 9.9 x 10-9 
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Figure 12: 
Vessel Wall 
V0/1 Willeorand IICIOf 
Ftbronociin 
The Interactions of flbrtnogen in response to vessel wall lesion. 
Interactions among platelet receptors, thrombin, flbrtnectin, 
von Willebrand factor, glycoproteins and flbrtnogen. They-
chain of flbrtnogen interacts with glycoproteins IIIa/Ilb, the 
receptors on the platelet. (Fuster et al, 1992). 
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(Hawiger et al, 1982). The staphylococcal receptor binding site in 
flbrinogen has been located on the y-chain between residues 397 -411 
(Strong et al, 1982). The valency of fibrinogen in regard to its receptor 
binding domain and the availability of this domain is essential for the 
staphylococcal clumping reaction. 
Fibrinogen has also been shown to induce the aggegation of 
erythrocytes (Maeda et al 198 7) and binds a multi-kringle containing 
lipoprotein(a), a plasma component whose concentration is related to 
the development of atherosclerosis (Fuster et al, 1992a,b). This 
binding is catalysed by plasmin (Harpel et al 1989). 
1.5 Assaying the degradation products of Fibrinogen and Fibrin 
.. 
The identification and measure of flbrinogenolytic degradation 
products (FgDP) and flbrinolytic degradation products (FbDP) in 
plasma remains an essential means of gauging physiological 
condition. A number of pathologic conditions are characterised by 
increased levels of FgDP and FbDP, thus the clinical utility of 
assaying the degradation products is well established. Earlier 
methods included gel filtration and SDS polyacrylamide 
electrophoresis analysis (Alkjaersig et al, 1977). The obvious 
limitation of these techniques was that reasonably high 
concentrations were required for any valid assay. What was required 
was a technique that could detect much smaller amounts and 
differentiate flbrtnogen and fibrin proteolysis products in plasma 
specifically. 
The rapid advances in the development of immunochemical detection 
techniques has held much promise for the development of 
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degradation product assays sensitive to fibrinogen antigens at low 
concentrations in plasma. These assay systems include 
radioimmunoassays and enzyme linked immunosorption assays 
(ELISA) (Wbitaker et al, 1985). Research emphasis in recent years 
has been focussed on removing the obvious limitation of using 
polyclonal antibodies to fibrinogen and/or fibrtnogen derivatives D 
and Eby developing specific monoclonal antibodies (Elms et al, 1986, 
Grumberg et al, 1987, Schielan et al, 1991). The monoclonal 
antibody DD-3B6/22 that is specific for the crosslinked fibrin 
derivatives (fibrin D-dimer/fibrin D-dimer-E fragment) used in a later 
agglutination procedure has led to the development of the solid phase 
'Dimertest' for flbrinolytic products in serum or plasma (Elms et al 
1986, Greenberg et al, 1987). The m.onoclonal Ab FDP-14 binds FgDP 
and FbDP but not parent flbrinogen. It has its epitope in the E-
domain of the flbrinogen molecule on the B~-chain amino acids 54-
118 (Kopper et al, 1987, 1988). Monoclonal antibodies have been 
raised using epitopes on the a-chain (Mao et al 1990) and they-chain 
(Schielan, 1991 ). 
While the immunologic approach is the most viable due to the high 
levels of sensitivity attainable, a severe limitation of the technique is 
the lack of absolute specificity of the antibodies especially as 
fibrtnogen is present in large amounts relative to low concentrations 
of FbDP and FgDP with short half lives. An accurate measure of 
flbrtnogen and fibrin degradation products in vivo requires assays 
that will distinguish with reasonable sensitivity between Y-D, (Y-D)XL 
(D-Y). Y, X, D, D-dimer and E 
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The need for an accurate assay for the specific analysis of flbrtnolytic 
degradation products cannot be emphasised sufficiently. In a recent 
review of coronary heart disease ( 1992) Fuster and colleagues 
implicate defective flbrtnolysis as a thrombogenic risk factor in 
patients with coronary disease. 
1.6 Snake Venom Enzymes and Fibrinogen 
Snake venoms are injected directly into the body through grooves on 
the fangs and the venom travels quickly into the bloodstream to be 
transported to their points of physiological action. It is not 
surprising, therefore, that a large number of snake venoms express 
their physiological toxicity in the blood, having a notable effect on 
coagulation. 
Snake venoms are a prolific source of enzyme, many have proved to 
be useful tools in coagulation studies, especially in the determination 
of f!brtnogen and fibrin structure and sites of polymerisation. At least 
26 enzyme types have been described, ten of which are common to all 
snake venoms; and the other sixteen are scattered throughout the five 
families of poisonous snakes (Russel, 1980). 
The snake venom enzymes affecting coagulation may be broadly 
divided into those with procoagulant activity (Fortova et al, 1990, 
Kirby et al, 1979, Niewiarowski et al, 1979) and those with 
anticoagulant activity (Pandya Budzynski, 1984, Pandya et al, 1983). 
The former may be subdivided into 
1) those enzymes that activate prothrombin to thrombin eg. enzymes in 
41 
venom of Echis carinatus (Morita & Bon, 1987a, b) and venom of 
Oxyuranus s. scutellatus (Walker et al, 1980): and 
2) the thrombin-Uke flbrinogenolytic enzymes eg. enzymes from the venoms 
of Bothrops jararaca (Maruyama et al, 1990), Crotalus atrox (Nika1 et 
al, 1983), ancrod of Agkistrodon rhodostoma and batroxubins from 
Bothrops moojeni and B.marajoenis (Muzbek & Hanek, 1979) as well 
as other Bothrops species (Nahas et al, 1979). and Cerastes vipera 
(Farid & Tu, 1989). 
There is a third class of snake venom enzymes of particular 
importance as tools for structural determinations, the flbrinogeno and 
flbrinolytic enzymes (Bajwa et al, 1980, 1981). These may belong to 
the procoagulant or anticoagulant ~ategories. The flbrinogenases may 
be further categorised according to which of the chains are digested, 
thus the a- and ~-fibrinogenases (EC. 3.4.21.5) (Ouyang et al, 1979, 
Ouyang & Huang, 1979, Moran & Geren, 1981, Teng et al, 1985). 
Finally, there are those venoms containing both procoagulant and 
anticoagulant factors eg. C.cerastes and C.vipera (Labib et al, 1981), 
B.gabonica and Agkistrodon c. piscivorus (Bajwa et al, 1982), and 
Agkistrodon C. contortrix (Dyr et al 1983). The snake venom 
proteases may be divided into the serine proteases (Kruzel & Kress, 
1985) or the zinc metalloproteinases (Evans, 1981, BJarnason & Fox, 
1983, Fox et al, 1986). The zinc(s) in the proteases may play a 
catalytic or structural role or in the case of some venoms eg. Crotalus 
atrox, both (Bjamason & Tu, 1978). There are also venom proteases 
that display a calcium ion dependence for activity eg. haemorrhagic 
principles from Crotalus h. horridus (Civello et al, 1983) and 
Agkistrodon contortrix (Dyr et al, 1989). 
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1.6.1 Puff Adder (Bitis arietans) Venom Proteases 
The venom of the Puff adder (Bitis arietans) exhibits a high 
haemorrhagic activity when tested in mice or rabbits (Homma & Tu, 
1971). Various researchers have attempted to isolate and purify the 
individual haemorrhagic principles (Morris et al, 1980, Morris & 
Lawrence, 1980, van der Walt, 1972, Purves et al, 1986). Mebs & 
Panholzer ( 1982) separated crude puffadder venom into 5 fractions, 
three displaying haemorrhagic activity. Lawrence and Morris ( 1981) 
isolated a potent, basic metalloprotelnase fraction from puffadder 
venom, Mr 24 000, that could destroy all detectable trypsin and 
chymotrypsin inhibitory activity when incubated with human plasma. 
The protease hydrolyses casein and effects the activation of plasma 
prekallikrein and inactive renin (Lawrence & Morris, 1981, Morris & 
Lawrence, 1980). 
Purves et al ( 1986) isolated a haemorrhagic principle from puffadder 
venom that displays flbrinolytic properties to be referred to as 'PAV 
protease'. The Mr 25 000 enzyme, with properties similar to van der 
Walt's protease A (1971), displays the ability to cleave flbrin-D-dimer 
into apparently symmetrical monomers (Purves et al. 1986, 1987, 
1989). Fibrin-D-dimer is the terminal plasmic digestion product of 
crosslinked fibrin in the presence of calcium. The PAV protease 
monomertsation of fibrin-D-dimer begins with a rapid cleavage of the 
di-y-chain followed by an independent progressive reduction of the ~-
chain (Purves et al, 1986, 1987). Sequence studies show that the PAV 
protease displays a unique site specificity on the di-y-chain, cleavage 
occurring between the Factor XIIIa (EC 2.3.2.13) catalysed crosslinks 
(Purves et al, 1987). 
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The activity is inhibited by EDTA but unaffected by the inhibitors 
hexane-diamine and PMSF (Purves et al, 1986). The protease 
hydrolyses casein but displays no EDTA-sensitive activity against 
chromozyms PL, PK, TRY and TH and demonstrates no esterolytic 
activity against tosyl-arginine-methyl-ester (Purves et al, 1986). 
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2. METHODS 
2.1. Preparation and purification of fluorescent-f-D-dimer, f-D-momomer 
and non-fluorescent ftbrin-D-dimer 
Preparation 
Fluorescent-D-dimer (f-DD) and fluorescent-D-monomer (f-D) was 
prepared as described previously (Purves et al, 1978a,b, 1986). 
Human ftbrtnogen (Sigma) was made up to lmg/ml in lOOmM Tris, 
pH 7.4, 150mM NaCl; and clotted at 37°C in the presence of 2.45 mM 
dansylcadaverine (Sigma) with lOOU of Thrombin (Parke-Davis) in 
5mM CaC12 (final). Dansylcadaverine, a fluorescent lysine analogue, 
was dissolved in 6M HCl and titrated to pH 7.00 with 6M NaOH before 
addition to the ftbrinogen solution. The fibrinogen preparation was 
sufficiently contaminated with Factor XUI to obviate the necessity of 
adding the transglutaminase. 
The resulting clot was spun down and washed repeatedly with and 
eventually homogenised in lOOmM Tris, pH 7.4, 150mM NaCl, lOmM 
CaC12 . The suspension was digested by 0.05mg/ml plasmin at 37°C. 
Plasmin was the product of the activation of l 0mg plasminogen 
(Sigma) by 500 Ploug units of Urokinase (Leo) in 2ml lOOmM Tris, pH 
7.4, 150mM NaCl. 
Purification 
The digest was filtered and dialysed against 5mM Tris, pH 8.6, lmM 
CaCl2, The dialysate was chromatographed on a (25 x 1cm) DE-52 
(Whatman) ion exchange column, eluting with 5mM Tris, pH 8.6 with 
a 0-300mM NaCl gradient to separate the D and E fragments. The 
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fractionation was analysed by SDS-polyacrylamide gel electrophoresis 
(Laernmli, 1970) on polyacrylamide gels with 6-15% density gradients. 
F-D-dimer and f-D-monomer containing fractions were pooled and 
-
concentrated with immersible CX-10 ultrafiltration units (Millipore). 
The f-D-dimer was separated from f-D-monomer by molecular sieving. 
The concentrate was loaded in no more than 2ml onto a ( 100 x 2.5cm) 
Ultrogel AcA 34 agarose molecular sieving column. Fractions were 
eluted with lOOmM Tris, pH 7.5 containing 150mM NaCl, lmM CaC12 
and 4M urea. An important restriction of the procedure was the low 
flow rates which were usually below 22.5 ml/hour. Increased flow 
rates resulted in the build up of excess pressure in the column. After 
SDS-PAGE analysis of the fractionation, the relevant fractions were 
pooled, dialysed to remove urea, arid concentrated. 
Non-fluorescent fibrin-D-dimer was prepared in the same manner but 
omitting the addition of dansylcadavertne. In the absence of the 
fluorescent lysine analogue, fibrin-D-dimer and the E fragment were 
the sole degradation products of plasmin digest of the clot, thus the 
DE-52 ion exchange chromotography proved to be an adequate 
purification technique eliminating the need for further molecular 
sieving or gel filtration of the fractions in the preparation of non-
fluorescent flbrin-D-dimer. 
2.2 Preparation of Puffadder Venom Protease 
Fresh puffadder venom was obtained from J. Visser, Hout Bay, Cape 
Town. The crude venom was taken up in 0.1 M Tris , pH 7.4 
containing 0.15 M NaCl and 1 mM CaC12 and filtered. The filtrate 
was subject to fast protein liquid chromatography utilising QMA 
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medium (Millipore) eluting with the same buffer. The fractionation 
was analysed on 6-15% SDS-polyaccylamide gels. The fractions were 
also analysed for f-D-dimer cleavage activity. This was determined by 
reacting each fraction with f-D-dimer in 0.1 M Tris, pH 7.4 containing 
150 mM NaCl, 1 mM CaC12 and 1 mM zinc acetate and the cleavage 
products were monitored on 6-15% polyaccylamide gels. The active 
fractions were pooled and concentrated using CX-10 ultraflltration 
units. These fractions were subject to molecular sieving on a 
Sephaccyl S300 (Pharmacia) (100 x 2.5 cm) column. The fractions 
were analysed by SOS-PAGE as well as for cleavage activity. 
2.3 Modification of flbrin-D-dimer with Diethylpyrocarbonate 
Diethylpyrocarbonate (ethoxyformi(? anhydride) is a specific 
modification agent for histidine and tyrosine residues. 
Diethylpyrocarbonate (BDH). 6. 78 M in ethanol, was added directly in 
0.5µ1 aliquots to a 2.5 ml of 0.15mM fibrtn-D-dimer solution in O. lM 
Tris, pH 7.37 with continuous stirring to a final concentration of 
5.42mM DEPC, at room temperature (Rogers et al, 1977). The 
modified protein DEPC-fibrtn-D-dimer was then separated from 
excess reagent on a PD-10 Sephadex G-25M column (Pharmacia). 
PD-10 G-25M columns are effective for desalting and removing low 
molecular weight molecules while large molecular weight molecules 
such as proteins pass through the gel filter unretarded. The columns 
were equilibrated with 25ml of O. lM Tris, pH 7.37. The sample was 
loaded in 2.5ml and this eluant was discarded. The DEPC-fibrtn-D-
dimer was then eluted with 3.5ml O. lM Tris, pH 7.37. 
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Regeneration of histidines 
The diethypyrocarbonate modification of the histidine and tyrosine 
residues in fibrin-D-dimer protein fragment was reverted with 
hydroxylamine. To 2.0ml of the DEPC-fibrin-D-dimer solution in 
O. lM Tris, pH 7.37; 0.5ml NH20H from a 360mM stock (25g/l) was 
added with stirring for 20 minutes at room temperature. The final 
hydroxylamine concentration was 59.5mM. All excess reagent was 
removed by gel filtration through PD-10 Sephadex G-25M columns 
(Melchior & Fahrner, 1970). 
2.4 Assay Techniques 
2.4.1 Polyacrylamide Gel Electrophoresis 
Polyacrylamide gel electrophoresis of proteins and peptide fragments 
were performed as per method of Laemmli (1970) in the presence of 
0.1 % sodium dodecylsulphate. The SDS-polyacrylamide gels were set 
up isocratically or with density gradients. The electrophoresis was 
performed in a Hoefer model SE600 electrophoresis apparatus 
drawing power from a Hoefer PS 1200DC power pack. A typical PAGE 
w~s run for 13 / 4 hours at 60mA at room temperature. All samples 
were treated with SDS before loading. In the case of analysis of 
reduced protein fragments, the disulphide bonds were reduced by 
incubation with ~-mercaptoethanol. Gels were run in 
Tris/glycine/SOS (TGS) buffer at pH 8.6. The tank buffer was 
prepared by dissolving 14.4g glycine, 3g Tris and lg sodium 
dodecylsulphate in H20 made up to 1 litre. 
The gels were stained in Commassie blue stain and destained in 
ethanol: acetic acid: water in 3: 1: 10 ratio . Commassie blue stain was 
prepared by dissolving 2.5g Commassie brilliant blue R-250 (Sigma), 
25Qg trichloroacetic acid (Sigma) in 750ml methanol and 1550 ml 
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2.4.2 
2.4.3 
water. When greater sensitivity was required, a silver staining 
technique was used as described previously (De Moreno et al, 1985). 
Densitometric gel scans were performed on a Helena Cliniscan II Gel 
Scanner. 
Protein Determinations 
Protein concentrations were determined utilising the Biorad protein 
assay. The assay is based on the observation that the maximal 
absorbance for Commassie Brilliant blue G-250 in an acidic medium 
shifts from 465 to 595 nm upon conjugation of the dye with protein. 
Using the molar extinction coefficient of the dye-protein complex and 
the Beers-Lambert law, it is possible to determine the protein 
concentration spectrophotometrically (Spector, 1978). A calibration 
curve of OD 595 vs concentration constructed from protein standards 
of lrnown concentration and the protein concentrations of the 
unlrnown samples are calculated from the calibration curve. 
The assay: To 100µ1 standard or unknown sample in a test tube, was 
added 5ml protein concentration dye reagent (Biorad). After standing 
for 5 min, absorbance was measured at 595nm. 
Chromozyme PL assay for plasmin activity 
Plasmin, activated from plasminogen by urokinase, was tested for 
activity using the substrate chromozym PL (Boeringer Mannheim). 
Chromozym PL, Mr 634.7, ls tosylglycl-prolyl-lysine-4-nitroanilide 
acetate. The assay buffer comprised lOmM Hepes, lOmM Trls/HCI, 
pH 7.8, lOOmM NaCl and I% polyethylene glycol 6000. 
The substrate was prepared by dissolving 20mg chromozym PL in 1ml 
water at pH 4.0 with HCI. 
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The assay was conducted as follows: To 1ml buffer in a cuvette was 
added 100µ1 substrate solution and 10µ1 plasmin/glycerol solution at 
2.5 mg/ml. The assay was monitored spectrophotometrtcally at 
405nm. 
2.4.4 Assaying the fibrinolytic activity of Puffadder venom protease 
The assay buffer used was O. lM Tris, pH 7.4, 0.15M NaCl, lmM 
CaCI2 and lmM ZnCI2 . The assay was conducted as follows: 20µ1 of 
f-D-dimer ( 1 7 µg / µl)was added to 25 µI buffer and 5 µI PAV protease 
(28 µg/ml). 
The reaction mixture was incubated for 90 minutes at 37°C. The 
reaction was terminated by adding an equal volume of SDS sample 
digest buffer containing EDTA. Sarpples were analysed on 6-15% 
SDS-polyacrylamide gels. 
For the studies of pH dependence, zinc concentration dependence and 
effect of enzyme concentration, the respective parameters were varied 
while the other parameters were kept constant. 
2.4.5 Differential Zinc Binding Study 
F-D-dimer and PAV protease samples were incubated independently 
in O. lM Tris, pH 8.0, lmM zn2+ buffer with 150mM NaCl for 90min 
at 25°c. Identical controls were set up in zinc-free O. lM Tris, pH 8.0 
containing 150mM NaCl. Extrinsic/unbound zinc was removed by a 
spin column procedure (Penefsky, 1977). 
Spin column desalting: Spin columns were set up in 2ml syringes 
plugged with glass wool and polypropylene discs. The syringes were 
filled with swelled 025 sephadex (Pharmacia). The columns were 
packed by centrifugation at 1200 rpm for 2mln. The eluant was 
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2.4.6 
discarded. The samples were loaded onto the column in l 00 µl 
volumes and spun at 2000 rpm for 5 min. The eluants were collected 
in Eppendorf micro test tu bes positioned in the centrifuge tu bes below 
the spin columns. 
The zinc incubated substrate and enzyme eluates were mixed with 
zinc-free enzyme and substrate respectively and assayed for PAV 
protease f-D-dimer digestion activity in 0. lM Tris, pH 8.0 with 150mM 
NaCl and lmM CaC12 in a time course study at 37°c. Aliquots of the 
reaction mixture were drawn at set time intervals and the reaction 
was stopped by the addition of an equivalent volume of SDS sample 
digest buffer containing 2mM EDTA and boiling. The protein 
products were analysed by PAGE 6-10% SDS-polyacrylamide gels 
(Laemmli, 1970). The gels were den·sitometrically scanned on a Helena 
Cliniscan II Gel Scanner. 
Absorption Spectroscopy 
Absorption Spectra were obtained on a Varian DMS 100 
Spectrophotometer fitted with a thermostated cell holder. The 
temperature was controlled by an external waterbath (Haake). All 
absorption spectroscopic studies were performed at 25°c in 1cm 
quartz cuvettes (Helma). 
2.4.6.1 Stoichiometric Determinations 
The wavelength of maximum absorption and molar extinction 
coefficient of dansylcadaverine were determined from the absorption 
spectrum of a stock solution of the fluorescent lysine analogue and 
application of the Beer's-Lambert law. The stoichiometry of the 
fluorescent dansyl groups per molecule f-D-dimer was calculated 
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from the difference spectra of dansylcadavertne conjugated f-D-dimer 
against the non-fluorescent protein (flbrtn-D-dimer) over the range 
220nm to 600nm. 
2.4.6.2 Cobalt-D-dimer Spectra 
Fibrin-D-dimer was diluted to 1.425 x 10-4M in O. lM Tris, pH 7.4 
degassed with helium. The spectrophotometer was baseline 
corrected for the buffer and the protein spectra in the visible 
wavelength range. Cobalt difference spectra were observed over the 
range 350nm to 800nm by titrating with CoC12 in 3mM increments. 
Similar spectral studies were conducted with diethylpyrocarbonate 
modified flbrin-D-dimer and with hydroxylamine-reverted 
DEPC-flbrtn-D-dimer. 
2.4. 7 Fluorescence Spectroscopy 
Fluorimetric monitoring of the PAV protease cleavage of f-D-dimer and 
the extrinsic fluorescence measurements were performed on a Hitachi 
F-3000 Fluorescence Spectrdphotometer fitted with a thermostated 
cell holder using 1 cm quartz cells (Helma). The cell temperature was 
regulated by an external waterbath. 
2.4.7.lPAV Digestion off-D-dimer 
The wavelengths of maximum excitation and emission for dansyl 
fluorescence were determined by performing excitation and emission 
scans independently. These were resolved at excitation: 340nm, 
emission: 520nm. All subsequent dansyl fluorescence 
measurements were performed using these wavelength parameters. 
The rate of cleavage of f-D-dimer by PAV protease was monitored as 
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the rate of decay of the absolute fluorescence of the dansyl 
fluorophore in the fluorescent conjugated substrate. The assay was 
performed as follows:_To cuvette was added 100µ1 of a 8.25 x 10-5M 
f-D-dimer solution and 900µ1 of assay buffer: 0. IM Tris, pH 8.0, 
I50mM NaCl, lmM ca2+. 
To examine the effect of zinc(II), the reaction was conducted in the 
presence of lmM zinc acetate. The reaction mixtures in the cuvette 
were stirred and incubated at 37°C and monitored fluorimetrically -
excitation: 340nm, emission: 520nm - in a time scan mode. 
2.4.7.2 Zinc Titration of Fibrin-D-dimer 
2.4.8 
\. 
Flbrin-D-dimer ( 1.78 x 10-7M) in O. IM Tris, pH 8.0 containing 
150mM NaCl was titrated with zri2+ at 25°c. The zinc stock 
solution used was concentrated (lOOmM zinc acetate) to reduce the 
-, 
dilution effects. The binding of zinc to the dimer molecules was 
monitored by determining the change in the protein intrinsic 
fluorescence that is dominated by tryptophan ( experimental 
sensitivity E<l>F = 11 x 10-2). The experimental sensitivity of a 
fluorophore is a product of the molar extinction coefficient and the 
fluorescence quantum yield (OF) (Cantor & Schimmel, 1980). 
Tryptophan fluorescence was determined with excitation wavelength 
280nm; emission 340nm (ref). zn2+ titration of DEPC modified 
flbrin-D-dimer was performed under the same conditions. 
Fluorescence Anisotropy 
Fluorescence polarisation measurements were performed on an 
Aminco SPF-500 Ratio Spectrofluorimeter fitted with a thermostated 
cell holder. The temperature was controlled by an external circulating 
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waterbath (Haake) fitted with a heater and compressor unit. The 
sample temperature was measured with a precalibrated digital 
thermometer with a probe inserted in a spare cuvette filled with 20% 
sucrose in the sample chamber. The sample chamber was flushed 
with dry nitrogen to prevent condensation. Fluorescence polarisation 
intensity measurements were taken over the temperature range 4°C 
to 40°c. 
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Fluorescence anisotropy (r) was calculated using equation 1 (Cantor & 
Schimmel, 1980). 
r= 
where In is the fluorescence intensity (in arbitory units when 
the excitation and emission polarised are in parallel and Ii is 
the fluorescence intensity with the polartsors perpendicular. 
The instrumental correction factor (g) consisted of the ratio of 
vertically to horizontally polarised emission with the excitation 
polariser in the horizontal plane (Brand & Witholt, 1967). 
2.5. EDTA Inhibition of PAV Protease Digestion of f-D-dimer 
Samples (5ml) of PAV protease in O.lM Tris, pH 7.4, 150mM NaCl 
were incubated with varying concentrations of EDTA - El : OmM, 
E2 : 2mM, E3 : 4mM, E4 : lOmM and E5 : 50mM EDTA for 10 min at 
35°c in a total volume of 25µ1 each. The EDTA incubated PAV 
protease samples and controls (0.5 µl enzyme/25 µl reaction solution) 
were individually mixed with 10µ1 f-D-dimer and 12.5µ1, O. lM Tris, 
pH 7.4, 150mM NaCl buffer. The mixtures were incubated at 37°C for 
20 min and reactions were stopped by boiling with an equal volume of 
SDS sample digest buffer. The samples were analysed on 6-15% SDS 
polyacrylamide gels for D-dimer cleavage activity. 
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Zinc and EDTA incubated PAV protease 
The effect of zn2+ on the EDTA inhibition of PAV protease activity was 
investigated as follows. zn2+ from a lOOmM Zinc acetate stock 
solution was added to samples from E2 to E5 in amounts to render 
the added EDTA and zn2+ equimolar;eg. to E3 that was incubated in 
4mM EDTA, zn2+ was added to a final concentration of 4mM. 
Samples E6 - E9 now contained equimolar amounts of EDTA and 
zn2+ ranging from 2mM to 50mM. The enzyme samples E6 - E9 were 
mixed with f-D-dimer and tested for f-D-dimer cleavage activity as 
described above. 
2.6 Computer modelling was done using the 'Desk Top Molecular 
Modeller' modeling programme available from Oxford University Press. 
The coordinates of the atoms in the crosslink peptide were estimated 
from a model built utilising a modelling kit and the structure was 
optimised using DTMM. 
The computer programme ESTA (Equilibrium Simulation for Titration 
Analysis) was used in determining the concentration of the free zinc(II) 
species in solution when analysing the binding of zinc(II) to f-D-dimer 
as monitored by changes in the intrinsic fluorescence of the protein 
fragment. The free zinc(II) was determined by setting up the 
appropriate model of all the species in the reaction solution and their 
respective formation constants (see results) and the programme 
calculated the equilibrium distribution of the chemical species in 
solution. 
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3. RESULTS 
3.1 Purification of f-D-dimer, f-D-monomer and fibrin-D-dimer. 
The plasmin digest of the fibrin clot contained three major protein 
components : the fluorescent f-D-dimer, f-D-monomer and non-
fluorescent E fragments. The digest was dialysed against 5 mM Tris, 
pH 8.6, 1 mM CaCI2 . The dialysate was fractionated on a DE-52 ion 
exchange column (Fig.13) using a 0-300 mM NaCl gradient. The 
f-D-dimer and f-D-monomer fragments eluted between 143mM and 
196mM NaCl. The E fragment eluted between 196mM and 250mM 
NaCl. The f-D-dimer and f-D-monomer containing fractions were 
pooled, concentrated and loaded in 1.5 ml volumes onto a ( 100 x 2.5 
cm) AcA 34 (Ultrogel) molecular sieve column. The molecular sieving 
resulted in the complete separation. of the monomer and dimer as 
evidenced in the SOS-PAGE analysis (Fig.14). 
3.2 Purification of the PAV Protease 
The clear yellow filtrate of Puffadder venom in 0.1 M Tris, pH 7.4, 0.15 
M NaCl, 1 mM CaCl2 was fractionated on a Mono Q column 
(Millipore). The fractionation was analysed on 6-20% SDS-
polyacrylamide gels (Fig.15b). Analysis of the f-D-dimer cleavage 
activity of the fractions (Fig.15c) associates the activity with an 
approximately 25000 dalton fragment. The highly active fractions 
were pooled, concentrated and gel filtered on a Sephacryl S300 
column. No further fractionation was ob.served, however, this 
partially purified preparation proved adequate for the subsequent 
digestion experiments and no other contaminating activities were 
observed. 
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Figure 13: The anion exchange fractionation of a plasmic digest of fibrin. 
The fibrin degradation products were eluted with a 0-300 mM 
NaCl gradient from a DE-52 (Whatman) (25 x 1 cm) column. 
The flow rate was 90 ml/hr. 
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Figure 14: The molecular sieving of the f-D-dimer and f-D-monomer 
containing fractions from the anion exchange fractionation. 
a) The fractionation was conducted on a (100 x 2.5cm) AcA34 
(Ultrogel) column eluting with 0.1 M Tris pH 7.5, 150 mM 
NaCl, lmM CaCI2 and 4 M urea. 
b) The fractionation was analysed on a 6-15% SDS-PAGE. The 
fluorescent bands were visualised under W-light (above). 
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Figure 15: Crude puffadder venom was subjected to ion exchange 
chromatography on a QMA (medium) monoQ (Millipore) 
column by FPLC. The elution buffer used was 0. lM Tris pH 
7.4, 150mM NaCl and lmM CaCl2. 
b) The fractions were analysed by 6-15% SDS-PAGE. 
c) The fractions were analysed for f-D-dimer cleavage activity 
(see text). The reaction mixtures were analysed by 6-15% 
SDS-PAGE 
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Figure 16: The gel filtration of the active PAV protease fractions from the 
QMA ion exchange chromatography. 
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3.3 Fluorescent-D-dimer and Fluorescent-D-monomer Dansylcadavertne 
Stoichiometry 
The absorption spectrum of a standard solution of dansylcadavertne 
( 1.52 x 10-4M) in O. lM Tris, pH 8.0, 150mM NaCl, lmM CaCl2, 
yielded an absorbance maximum at 326nm. The Beer-Lambert law A 
= Eel was used to determine the molar extinction coefficient 
maximum of the dansyl group: E = 3.56 x 103 M-1 cm-1. 
Analysis of the difference spectra of f-D-dimer against non-fluorescent 
flbrtn-D-dimer (Fig.18b) calculated a ratio of 
dansylcadavertne: f-D-dimer = 1.218 x 10-5M: 7.25 x 10-6M. 
This reduces to a stoichiometry of 1. 77: 1. 
The dansylcadaverine: f-D-monomer stoichiometry was calculated as 
1.09: l in a similar manner. 
Determination of the fluorescence/ concentration ratios. 
For this investigation, three random f-D-dimer samples and three 
f-D-monomer samples were chosen from the molecular sieved 
fractions from Ultrogel AcA34 fractionation. The sample purity was 
checked by SOS-PAGE. The protein concentration of each sample was 
accurately determined using the BioRad method and the absolute 
fluorescence - excitation: 340nm, emission: 520nm - was determined. 
From the data, the absolute fluorescence/protein ratio was 
determined. The ratio of the absolute fluorescence per protein 
molecule of f-D-dimer to f-D-monomer was calculated as 2.05: 1. 
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Figure 1 7: The Absorption profile of dansylcadavertne in O. 1 M Tris 
pH 8.0, 150mM NaCl, lmM CaCl2, Peak maximum was 
observed at 326 nm. 
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Figure 18: The UV absorption profile of 
a) f-D-monomer in O. lM Tris 8.0, 150mM NaCl, lmM CaCl2, 
The dashed line represents the absorption profile of non-
fluorescent flbrin-D-monomer. 
b) F-D-dimer in the buffer above. The absorption proflle of 
non-fluorescent flbrin-D-dimer (- --) was subtracted from 
the f-D -dimer spectrum to calculate the dansylcadaverine: 
f-D-dimer stoichiometry (see text). 
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3.4 The Phenomenon of PAV Protease f-D-dimer cleavage 
3 .4.1 The PAV protease cleavage of f-D-dimer 
The digestion of f-D-dimer with PAV protease in 0.1 M Tris, pH 7.4, 
0.15 M NaCl, lmM CaC12 and 1 mM zinc acetate results in the 
cleavage of the di-y-chain and digestion of the ~-chain. Time course 
studies analysed on SDS-PAGE indicate that the monomerisation of 
the dimer by cleavage of the di-y-chain to produce PAV-D-monomer, a 
peptide fragment of lower molecular weight than the plasmin-derived 
monomer is the first event, followed by the subsequent hydrolysis of 
the ~-chain. 
The pH dependence of the digestion was tested over a wide pH range 
(Fig.19). The enzyme is active over .the range pH 6.4 - pH 9.75 but 
maximal in the pH range 7.0 - 8.0. 
3.4.2 Extrinsic Fluorescence of f-D-dimer during PAV Digestion 
The decrease of absolute fluorescence of f-D-dimer is an indication of 
the cleavage of the substrate (Purves et al, 1986). The fluorescence 
decay data (Fig. 21) was fitted by a least squares method using the 
Levenberg-Marquardt algorithm (Marquardt. 1963). The f-D-dimer 
cleavage data, both in the presence and absence of zinc was fitted 
best by a biexponential (equation 2), implying a biphasic reaction. The 
flt lead to the deduction that a rapid phase occurs first followed by a 
slower second phase. 
Y - F + AF~ t e-kfast.t + AF~ t e-kslow.t 
- oo 1.as 1.as 
where F = fluorescence (Ex 340nm, Em 520nm) at saturation. 
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Figure 19: 
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~B1 
The pH-dependence of the PAV protease digestion off-D-dlmer. 
Lanes 2 and 3 are the f-D-dimer and f-D-monomer. The activity 
was tested at pH 1. 75 
(Lane 4), pH 3 .35 (Lane 5), pH 6.40 (Lane 6), pH 7.53 (Lane 7), pH 
8.36 (Lane 8) and pH 9.75 (Lane 9). 
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Figure 20: Effect of zinc(II) ions on the PAV protease digestion of f-D-dimer. 
The digestion was conducted in O. lM Tris, pH 7.4, 150mM NaCl, 
lmM CaCl2 and, OmM zinc(II) (Lane 4), 0.5mM zinc(II) (Lane 5), 
lmM zinc(II) (Lane 6), 2mM zinc(II) (Lane 7), 5mM zinc(II) (Lane 8) 
and lOmM zinc(II) (Lane 9). The cleavage of the di-y-chain 
occurred at all concentrations of zinc(II) with optimum activity in 
the range 0 .5 - l.OmM. The digestion of the ~-chain occurred 
over the range 0.5mM - 2mM. 
~F fast = change in fluorescence for the fast phase of the 
reaction. 
~F slow = change in fluorescence for the slow phase 
kfast and kslow are the reaction rate constants for the fast and 
slow phases respectively. 
The rate constants of the PAV protease digestion off-D-dimer in O.lM 
Tris, pH 8.0, 150mM NaCl, lmM CaCl2 were 
kfast = 0.220 + 0 .040 min-1 
kslow = 0.044 + 0.017 min·l 
The rate constants of the PAV protease digestion of f-D-dimer in O. lM 
Tris, pH 8.0, 150mM NaCl, lmM Cac12, lmM zn2+ were 
kfast = 0. 910 .±. 0.010 min - 1. 
kslow = 0.100 + 0.070 min- I 
The flourescence data off-D-monomer PAV protease digestion in 0.lM 
Tris, pH 8.0, 150mM NaCl, lmM CaC12 was fitted to a 
monoexponential curve: 
F(t) = F00 + (F0 - F00) e·kt 
where F O = Fluorescence at t = 0 
indicating a monotonic decay. The rate constant was calculated at 
k = 0.433 + 0.017 min· 1. 
The results indicate that for the PAV protease digestion of f-D-dimer, 
a 4.136 fold protentiation of activity in the presence of zn2+ ions was 
noted. 
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Figure 21: Effect of zinc ions on the PAV protease digestion of f-D-dimer. 
The progress of the reaction was monitored by measuring the 
decay of fluorescence of the conjugated dansyl moiety -
excitation 340 nm; emission 520 nm - expressed as a 
percentage of initial fluorescence. The digestion conducted ( 1) 
in the absence of zinc ions and (2) in the presence of 1 mM 
zn2+ (zinc acetate). Points on the curve were digitised at 
regular intervals utilising a graphics tablet ( Summa Sketch II) 
and analysed by least squares. The protease cleavage of 
f-D-dimer was potentlated 4.136-fold in the presence of zinc 
ions.(kfast = 0.91 ± 0.01; kslow = 0.01 ± 0.07) 
Inset: The PAV protease digestion of f-D-monomer. Monotonic 
decay was observed indicating a monophasic reaction. The 
rate constant was calculated at k = 0.043 + 0.02. 
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3.4.3 EDTA inhibition of PAV protease f-D-dimer cleavage activity 
PAV protease has been shown to be unaffected by protease inhibitors 
such as phenylmethylsulphonyl fluoride and hexanediamine (Purves 
1986). The.EDTA inhibition of PAV protease cleavage of f-D-dimer was 
evaluated by a measure of f-D-dimer substrate remaining uncleaved 
after 20 minutes reaction (Fig.22a). 
The control enzyme sample untreated with EDTA or zinc, cleaved 51 % 
of the f-D-dimer substrate after 20 min; the E2 sample (in 2mM 
EDTA) cleaved 8.82%, E3 (4mM EDTA) 5.03%, E4 ( lOmM EDTA) 
1.87% and E5 (50mM EDTA) displayed 100% inhibition of activity. 
The Zinc treated EDTA incubates of the enzyme displayed a 
regeneration of activity to varying d~grees. The activity of the enzyme 
sample incubated in 50mM EDTA could not be regenerated with zinc. 
PAV protease is a zinc metalloproteinase and EDTA (ethylenediamine 
tetra-acetic acid) is a metal ion chelator. The PAV protease cleavage of 
f-D-dimer proceeds even in the absence of extrinsic zinc, therefore 
EDTA inhibition of activity must result from a chelation of zinc or 
other metal cations bound to the enzyme. This chelation alters the 
enzyme structure sufficiently to affect inhibition. The inhibition was 
approximately 82% at 2mM EDTA and 100% at 50mM EDTA. The 
activity was regenerated in some incubates by adding zinc to the 
EDTA incubated enzyme in equimolar quantities. The zinc treated 
samples of enzyme incubated with 2mM (E6) and 4mM (E7) EDTA 
were regenerated to 100% activity and there was sufficient zn2+ in 
excess to potentiate the activity even further. The lOmM (E8) EDTA 
incubate was regenerated to 46% activity and the 50mM (E9) 
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Figure 22: The EDTA inhibition of PAV protease digestion of f-D-dimer 
and regeneration of activity by the addition of zinc(II). 
The EDTA incubates and the zinc treated EDTA incubates of 
PAV protease were tested for f-D-dimer digestion activity (see 
text). 
a) The reactions were analysed by SDS-PAGE; f-D-dimer was 
incubated with El (Lane 4), E2 (Lane 5), E3 (Lane 6), E4 
(Lane 7), E5 (Lane 8), E6 (Lane 9), E7 (Lane 10), E8 
(Lane 11), E9 (Lane 12). 
b) The densitometric analysis of the EDTA treated PAV 
protease samples and the zinc treated EDTA incubated 
PAV protease samples .. 
EDTA incubate not at all. This leads to the speculation that the 
zinc atoms bound to the enzyme protein are divided into structural 
and catalytic types. The inhibition resulting from the chelation of 
catalytic zincs at lower EDTA concentrations was easily reversed with 
zinc addition, but at higher EDTA concentrations, structural zincs 
were chelated out of the enzyme inducing irreversible structural 
changes and thus, activity could not be regenerated. 
3.5 Zinc and the D-dimer fragment 
3.5.1 Differential Zinc Binding Study 
3.5 .2 
The differential zinc binding study provided a means of determining 
whether the zinc potentiation of flbrin-D-dimer digestion by the snake 
venom enzyme was due to a zinc-substrate interaction, a zinc-enzyme 
interaction or both. 
The gel scan data for both the zinc incubated substrate and native 
substrate were fitted best by least squares to bi-exponential equations 
corroborating the fluorescence data (Fig. 23). The snake venom 
digestion of the zinc bound f-D-dimer species yielded a rapid phase 
rate constant 
kfast = 0.55 ± 0.04 min-1 and the native f-D-dimer species 
kfast= 0.20 ± 0.06 m1n·l. This represents a zinc potentiation of2.75 
fold. The zinc incubated PAV protease yielded negligible potentiation 
of activity when compared with the native enzyme. 
Intrinsic Fluorescence changes in f-D-dimer due to Zinc binding 
The intrinsic fluorescence of proteins is due primarily to tryptophan 
residues [experimental sensitivity (E<I>F = 11 x 10-2)) with additive 
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Figure 23: The differential zinc study. 
a) 6-10% SDS-PAGE ofa time course reaction of the PAV 
protease digestion of native f-D-dimer (i). 
b) 6-10% SDS-PAGE of the time course reaction of the PAV 
protease digestion of f-D-dimer incubated with lmM zinc. 
Zinc acetate (ii). 
c) The densitometric quantitation of f-D-dimer substrate 
during the PAV digestion in zinc free buffer. 
i) f-D-dimer incubated in 0. lM Tris, pH 7.4, 150mM NaCl, 
lmM CaCl2 ( • ). 
ii) f-D-dimer incubated in 1 mM zinc acetate, 
0.1 M Tris, pH 7.4, 150mM naCl, lmM CaCI2 (e ). 
Free zinc was removed by a 025 spin column procedure before 
the f-D-dimer was added to the PAV. 
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Figure 24: Intrinsic fluorescence changes during titration of f-D-dimer 
samples (1.78 x 10-7 M) in 0.1 M Tris, pH 8.0 were titrated 
with increments of zinc(II) ions. The change in tryptophan 
fluorescence was used to monitor the binding (see text). 
Intrinsic fluorescence was determined - excitation, 280 nm; 
emission 340 nm. 
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Figure 25: Scatchard plot analysis of zinc binding to f-D-dimer. The data 
was fitted using least squares. The plot yielded a slope (-kn) of 
'I 
-7594 + 9.96 M-1 and Y intercept of 
1.706 X 10-3 + 0.06 X 10-3. 
The X intercept yields binding sites 
n = 1.26. Data points at high [Zn2+] could not be reliably 
obtained due to the formation of significant concentrations of 
insoluble zincate complexes. 
75 
14 
12 
:E 10 
(0 
/ 
/ 
I 
0 8 
oir- / 
)( 
-
/ Q) 6 +-' re, 
0 / 
C: 
N 4 
-
2 
00 200 400 600 800 1000 
Total [Zn2 + l x 1 o·6 M 
Figure 26: The corresponding increase in the zincate concentrations with 
progressive increments of zn2+ (---) represents the [Zn(OH)+] 
and(-) the [Zn(OH)z]. 
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contributions from tyrosines when present in large numbers 
(E<l>F = 2 x 10-2) (Cantor & Schimmel, 1980). The intrinsic 
fluorescence of a protein is sensitive to conformational change and, in 
the absence of protein-protein associations and gross denaturation, 
changes in tryptophan fluorescence can be attributed to structural 
perturbations brought about by ligand binding (Lakowicz, 1984). 
The flbrin-D-dimer zinc titration data is represented graphically in 
Fig.24. The concentrations of the free zinc species and the zn2+ 
complexes in reaction solution were determined using the computer 
programme ESTA (Equilibrium Simulation for Titration Analysis) (May 
& Murray, 1988). This programme calculates the distribution of 
significant species in solution from known equilibrium constants for 
each of the complexes. 
The following model was set up for the system of zn2+ in O. lM Tris, 
pH8.0. 
~H 
tt+ + ott· 
·--- H20 -13.950 
tt+ + Tris ~ HTris+ 8.073 
zn2+ + Tris :;:=:::= Zn(Tris)2+ 2.270 
zn2+ + OH· ___::.. Zn(OH)+ -8.950 
zn2+ + 2ott· ~ Zn(OH)2 -16.800 
zn2+ + 30H· ~ . Zn(OH)3 · -28.250 
zn2+ + 40H· ~ Zn(OH)42· -41.250 
2zn2+ + OH· ~ zn2ott3+ -8.950 
where PH = log k with respect to H+ 
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Figure 27: The calculated and measured concentrations of protein bound 
zinc species (zinc-f-D-dlmer) produced with increasing 
increments of zinc. 
( • )Indicates the concentration of the zinc-f-D-dimer species 
measured from experimental data. The solid line represents 
the species concentration as predicted by the programme 
ESTA. The close correlation is indicative of the suitability of 
the programme for the analysis of such titrations. 
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The program calculates the concentrations of each individual species 
of complex at each titration point from the total zn2+ Tris, free H+ 
concentrations and the pH values of the significant complexes. All the 
equilibrium constants were obtained from Martell & Smith ( 1974). The 
constants were expressed in pOH, from which ~H was calculated 
using log kw= 13.95. 
Assuming a stoichiometry of 1 zinc atom per D-dimer molecule, a 
binding constant of log k = 4.0 I ±. 0.04 was calculated. 
ESTA also calculated the concentrations of the zincate species 
(Fig.26). 
.. 
Scatchard Plot Analysis of Titration Data 
A Scatchard plot is a plot of v /L vs v. The plot is linear with 
Y intercept n/kd , X intercept = n and slope = -1 /kd, and 
therefore the binding constant k = negative slope of the line. 
When the titration data was analysed with Scatchard plots (Fig.25 ), a 
binding constant of log k = 3.88 ±.0.01 was found and binding sites n 
= 1.26. 
It is important to note that a fundamental limitation to the zinc 
titration experiments was the high concentration of precipitable zinc 
hydroxides generated (Fig.26) making it difficult to obtained 
reasonable data at high concentrations of zinc(II). 
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Table Zinc titration of D-dimer by Intrinsic Fluorescence 
' Total [Zn] · [Bound Zn] L [Bound Prot] [Free Zn] Log k 
x10-6 Xl0- 8M X10-5M [Free Prot] Xl0-5M 
50 0.949 4.99 0.0563 0.510 4.04 
100 1.660 9.99 0.1028 1.020 4.00 
150 2.550 14.99 0.1672 1.531 4.04 
200 2.848 19.99 0.1904 2.043 3.97 
250 3.441 24.99 0.2396 2.555 3.97 
300 3.896 29.99 0.2802 3.067 3.96 
350 4.549 34.99 ·o. 3433 3.580 3.98 
400 5.083 39.99 0.3997 4.093 3.99 
. .. 
.. 
450 5.617 44.99 0.4610 4.606 4.00 
500 6.131 49.99 0.5254 5.120 4.01 
550 6.527 54.99 0.5825 5.634 4.01 
600 6.922 59.99 0.6363 6.140 4.01 
650 7.417 64.99 0.7143 6.664 4.03 
700 8.386 69.99 0.8907 7.179 4.09 
750 8.425 74.99 b.8987 7.695 4.06 
.... 
3.5.2.1 Diethylpyrocarbonate Modification of fibrin-D-dimer 
Diethylpyrocarbonate is a specific modification agent for histidine and 
tyrosine residues (Rogers et al, 1977; Melchotr & Fahrney, 1970) 
(see Addendum II). The acid anhydride modifies unsaturated 
nitrogens which would normally be available to ligand metal cations. 
The diethylpyrocarbonate modification of fibrin-D-dimer was tested by 
monitoring the 00242 of the reaction solution. When the DEPC 
modified fibrtn-D-dimer was titrated with zinc, no changes in the 
tryptophan fluorescence were observed (Fig.28). The lack of structural 
perturbations indicated that the modified protein was not binding 
zinc. This implicated the histidine residues as ligands for 
coordinating the zinc atoms. 
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Figure 28: Zinc titration of diethylpyrocarbonate modified flbrin-D-dimer. No 
significant change in intrinsic fluorescence was observed with 
increasing increments of zinc(II) when the histidine residues of 
f-D-dimer were modified with the acid anhydride. 
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3.5.3 Fluorescence Anisotropy 
The fluorescence polarisation characterisation of the two species: f-D-
dimer and zinc-f-D-dimer was examined by fitting the fluorescence 
polarisation data into the Perrin equation. 
= + (3) 
1 1 
r 
where 1 /r0 is the reciprocal of the extrapolated anisotropy 
at the Y intercept. 
k is the Boltzman constant, k = 1.38 x 10-23 JK-1 
'tf is the fluorescence lifetime of the excited fluorophore; 
't(Dansyl) = 13 x 10-9s (Cantor & Schimmel, 1980a) 
ll is the viscosity of the solution, in this instance 20% sucrose 
obtained for each temperature from Weast ( 1987) 
Vh is the molecular volume (spher1cc3:l hydrated volume). 
Plots of 1 /r vs T Ill produced straight lines (Fig.29) 
with y intercept 1 fro and slope 'tf< / r0 Vh 
The fluorescence anisotropy data of f-D-dimer in the absence and in 
the presence of zinc when analysed by Perrin plots had the same Y 
intercept at 2.674 ±. 0.065. The slopes of the Perrin plots were 1.205 
x 10-2 ±. 3.6 x 10-4 cPK-1 (centipoise per Kelvin) for f-D-dimer in O. lM 
Tris, pH 8.0 with 150mM NaCl, lmM CaCI2 and 20% sucrose; and 
1.025 x 10-2 + 6.31 x 10-3 cPK-1 for f-D-dimer in the same buffer but 
in the presence of lmM zn2+ . 
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Figure 29: Perrin plots of f-D-dimer in the absence(• ) and presence (e ) of 1 
mM zn2+. Fluorescence polarisation measurements were 
taken in 5°c and 5o0c. The horizontal axis is T /ri where Tis 
the temperature in Kelvin, and ri the viscosity in poise of 20% 
sucrose at the given temperature. The ordinate represents the 
reciprocal of the anisotropy measured - excitation, 340nm; 
emission, 520nm. Both zinc conjugated f-D-dimer and native 
f-D-dimer have the same ordinal intercept. The slope of the 
zinc f-D-dimer species was calculated at 1.205 x 10-2 cPK-1 
and that of the native zinc free species 1.025 x 10-2 cPK-1. 
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The spherical hydrated volume (Vh) of f-D-dimer in lmM zn2+ was 
calculated at Vh (Zn-f-DD) = 4.68 x 10-20cm3 and for zinc-free 
f-D-dimer: Vh (f-DD) = 3.98 x 10-20cm3. The results indicated a 
17.58% larger (spherical model) volume for f-D-dimer in the presence 
of zinc. 
Since volume of sphere = 4 / 3Dr3; the spherical volume of the 
Zn-f-D-dimer species corresponds to radius of 2.235 x 10-7 cm and 
the 
f-D-dimer species 2.118 x 10-7 cm. The zinc induced a radius increase 
of 5.52% in the spherical volume of the f-D-dimer species. These 
results indicate a zinc induced conformational change in f-D-dimer. 
3.5.4 Cqpalt Absorption Spectroscopy ... 
Zinc(II) is a spectroscopically silent d 10 system. Substitution of 
zinc(Il) with chromophoric paramagnetic Co(II), a d7 system, results in 
a cobalt conjugate that is spectrally sensitive to changes in the metal 
environment (Martin et al, 1989, Bertini & Luchinat, 1984, Lever, 
1984). The cobalt visible spectrum is also characteristic of the 
coordination number of the metal ion as well as the geometric shape 
of the inner coordination sphere (Lever, 1984). 
3.5.4.1 Absorption Spectra of Cobalt-flbrin-D-dimer 
The spectrum of lOOmM [Co (H20)J2+ complex was observed against 
a \Vater reference. The defining parameters were "-max= 511nm and 
molar extinction coefficient e = 4.69 M- lcm-1. 
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Figure 30: The cobalt titration of flbrin-D-dimer as monitored by absorption 
spectroscopy over the wavel~ngth range 350nm to 800nm. The 
figure represents the difference absorption spectra obtained 
when flbrin-D-dimer was titrated with a) 0 mM, b) 3.8 mM, 
c) 7.4 mM and d) 10.2 mM C0Cl2 (see text). 
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Figure 31. The binding of cobalt to fibrin-D-dimer. The difference spectrum 
of protein solutions with and without added cobalt was 
obtained. A single absorption band was observed with peak 
maximum at 545 nm (v:::: 18 348 cm· I) for the cobalt-fibrtn-D-
dimer complex in 0.1 M Tris, pH 7.4. The molar extinction 
coefficient maximum for the complex was calculated at 
210.52 M·l cm·l. 
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When a 1.425 x 10-4M solution of flbrin-D-dimer (non-fluorescent) 
was titrated with cobalt after baseline correcting for buffer and protein 
spectra. the difference spectrum observed over the range 350 nm -
800 nm was characterised by a single broad peak with Amax = 545nm 
ie (v = 18 348 cm-1) (Fig.SO). The protein solution was titrated to 
saturation with Co(II) (Fig.3 1 ). The maximum molar extinction 
coefficient was calculated at 210.52 M-1 cm-1. 
Generally a Cobalt(II) complex with molar extinction coefficient in the 
range 102 _ 103 M-1 cm-1 is characteristic of cobalt in a tetrahedral 
environment. thus the results would indicate that the Co(II) in 
flbrin-D-dimer is a tetrahedral coordination capsule. The wave 
number v = 18 348.6 cm-1 corresponds to a 4T1 (P) -4A2 transition in 
a tetrahedral environment (Lever, 1984). 
3.5.4.2 Absorption Spectra of Cobalt-DEPC-fibrin-D-dimer and 
Hydroxylamine Regenerated flbrin-D-dimer 
Diethylpyrocarbonate modified fibrin-D-dimer was titrated with co2+ 
under the same conditions as the native fibrtn-D-dimer. No difference 
spv!ctrum was observed in the visible wavelength range. The 
ethoxyformic anhydride specifically modifies histidine residues. The 
absence of a difference spectrum indicates that Co(II) is not bound to 
the fibrin-D-dimer due to the unavailability of the imidazole rings of 
histidine for metal ion coordination. 
Hydroxylamine (NH20H) regenerates diethylpyrocarbonate modified 
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histidine residues (Melchior & Fahrney, 1970). When hydroxylamine 
treated DEPC modified flbrin-D-dimer was titrated with cobalt(ll), 
characteristic (absorption) difference spectra were again observed. The 
maximum molar extinction coefficient Emax WaS Calculated at 
168.65 M· l cm· 1. The regeneration of the histidine residues results in 
the recovery of the absorption spectrum, implying that cobalt is again 
bound to the protein. This proves unambiguously that the cobalt is 
bound to histidine residues on flbrin-D-dimer. 
It was crucial to remove all excess acid anhydride prior to treatment 
with hydroxylamine to prevent the formation of contaminating 
oxazoles and pyrazoles. The lower Emax of the hydroxylamine-
treated-DEPC-flbrin-D-dimer is due to the fact that not all the 
histidine residues are regenerated. 
3.6 Effect of Other Metal Cations 
In addition to zinc(II), the effect of Cd(II). Cu(II), Co(II) and Mg(II) on 
the PAV protease digestion of f-D-dimer was examined. The SOS-
PAGE analysis of the reaction indicates that the digestion of the D-
dimer fragment occurs in the presence of all the tested divalent 
cations. In all five cases, the major product of the digestion was the 
D-PAV-monomer fragment (Fig.32). 
Only in the presence of zinc was digestion of the ~-chain observed 
which leads to the deduction that the hydrolysis of the ~-chain 
requires Zinc as a <?O-factor. In the presence of lmM Cd, in addition 
to the D-PAV-monomer fragment, the other major product was a 
protein fragment with the same Rf value as plasmin derived D-
monomer. In the presence of Cu the rate of the reaction was 
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Figure 32: The effect of divalent metal cations on the PAV protease digestion of 
f-D-dimer. Lanes 1 and 2 represent f-D-dimer and f-D-monomer 
respectively. All reactions were performed in 0.1 M Tris, pH 7.4, 
150 mM NaCl, 1 mM CaCl2. Reactions were performed in the 
presence of zinc(II) (Lane 4), cadmium(II) (Lane 5), copper(II) 
(Lane 6), cobalt(II) (Lane 7) and magnesium(II) (Lane 8). 
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significantly decreased when compared with the control. 
In addition to zinc, the binding of cadmium (Cd) and aluminium (Al) 
to fl.brin-D~dimer was examined by measuring the changes in intrinsic 
fluorescence of the protein upon titration with the cation (Fig.24). The 
decrease in tryptophan fluorescence with increasing titres of Cd and 
Al indicates that both these metal cations bind to the macromolecule. 
Due to the high concentrations of metal hydroxides, no acceptable 
data could be obtained at higher metal ion concentrations. The 
binding constants of the liganding of Cd and Al to flbrin-D -dimer 
could not be calculated to a satisfactory accuracy due to the lack of 
sufficient titration data points. 
4. DISCUSSION 
Puffadder venom protease exhibits a unique ability to cleave the 
flbrin-D-dimer fragment into apparently symmetrical monomers. This 
occurs with a site specific cleavage of the D-dimer di-y-chain and 
subsequent slower digestion of the j3-chain (Purves et al, 1986). They-
chain cleavage site was located by sequencing studies as being within 
the di-y crosslinked region at the bond between y-chain residues 0404 
and A-405 on each 
y-chain and accompanied by the heterogenous loss of 401 HLGG 404 
with both Factor XIIIa-induced crosslinks still intact. 
n ...... QQHHLGGAKQAGDV 411 
I I 
411VDGAQKAGGLHHQQ ..... n 
PAV h 401 n ••••• QQH ( ) 
I 
411VDGAQKA405 
where (I) indicates crosslinks 
(Purves et al., 198 7) 
X 2 
The enzyme is active over a wide pH range. In the presence of zinc, 
' the di-y-chain cleavage activity is observed over the range pH 6.40 -
pH 9. 75. The j3-chain digestion activity is zinc dependent and has a 
smaller pH range; 6.40 - 8 .5. This is accounted for by the fact that at 
higher pH values, the predominant complexes of zinc would be the 
zincates Zn(OH)2 and Zn(OH)+ and even Zn(OH)42- leaving only small 
concentrations of free zn2+ in solution to act as a cofactor for j3-chain 
digestion. The PAV protease digestion of f-D-dimer is potentiated by 
the presence of zinc(II) ions. Analysis of the digestion with 
fluorescence measurements using a fluorescent conjugated substrate 
calculates the potentiation as 4.136 fold. The zinc induced 
enhancement of the the reaction rate could be due to 
an interaction of zinc(II) with either the enzyme or substrate or both. 
These possibilities were investigated in a differential zinc binding 
study, the results of which indicated a negligible potentiation through 
the enzyme, but a significant potentiation through the protein 
substrate. 
' 
These findings were further reinforced when changes in the intrinsic 
tryptophan fluorescence (Ex 280nm, Em 340 nm) were observed when 
the protein was titrated with zlnc(II). Sodium dodecylsulphate 
polyacrylamide gel electrophoretic analysis showed a total absence of 
gross protein denaturation or protein-protein associations. therefore 
the changes in intrinsic fluorescence on zinc titration could only be 
attributed to structural perturbations brought about by ligand 
binding to the macromolecule. When the titration data was analysed 
with the assistance of the computer programme ESTA with the 
primary assumption of a Zn: flbrtn-D-dimer stoichiometry of l: I. a 
binding constant for the binding of zinc to flbrin-D-dimer was 
calculated at log k = 4.01 ±.0.01. Scatchard analysis of the data 
confirms the zinc: flbrin-D-dimer molar ratio of 1: I. binding sites n = 
1.26. and calculates binding constant of log k = 3.88±.0.01 
The fluorescence anisotropy measurements of fluorescent-D-dimer in 
the presence and in the absence of zinc(II) ions, when analysed by 
Perrin plots, reveals an 18% increase in the calculated volume 
(spherical hydrated model) of f-D-dimer in the presence of zinc. 
According to the model developed by Perrin and others, each 
fluorophore may be visualized as a set of absorption and emission 
dipoles. 
,; 
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These dipoles are characterized by definite spatial relationships to 
each other and to the axes of the molecule. The rotational relaxation 
times of the fluorescence anisotropy are directly related to molecular 
shape and size (Brand & Witholt, 1967}. The native f-D-dimer and the 
Zn-f-D-dimer species have the same r0 value, ie. the anisotropy at 
T /Y) = 0 which would indicate that the zinc induced conformational 
change is localised and that the basic structure of macromolecule 
remains unchanged. The fluorescence anisotropy measurements 
confirm that zinc binds to f-D-dimer in a manner that induces a 
region specific or localised conformational change in the protein. 
The coordination state and configuration of the coordination capsule 
of the bound metal ion was determined by studying a cobalt-flbrin-D-
dimer complex. Cobalt(II) ([Ar]3d7ns frequently substituted for the 
spectroscopically silent zinc(II) to characterise complexes as the 
optical absorption spectrum is sensitive to the nature of the 
coordination state (Frankel et al, 1987). The cobalt-flbrin-D-dimer 
complex absorption profile in the visible spectral range; 
350nm - 800 nm, has a single broad absorption peak with peak 
maximum at v = 18348 cm· l and maximum molar extinction 
co~fflcient of Emax = 210.52 M· lcm· l. This ls characteristic of high 
spin cobalt(II) complexes when the cobalt is bound in a tetrahedral 
coordination capsule ( e = I o2 - 1 o3 M- I cm· 1) with d-d transitions 
that are spin allowed and Laporte forbidden (Lever, 1984). 
Diethylpyrocarbonate specifically modifies histidine and tyrosine 
residues (Rogers et al. 1977, Melchior & Fahrney, 1970). The acid 
anhydride modifies unsaturated nitrogens on histidine that would 
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normally be available to ligand metal cations. No zinc binding was 
apparent when DEPC-flbrin-D-dimer was titrated with zinc and 
monitored by tryptophan fluorescence changes. The DEPC-modified 
protein fragment also failed to complex Co(II) as evidenced by the 
absence of an absorption peak in the difference visible spectrum on 
titration with cobalt, therefore the DEPC modification of 
flbrin-D-dimer rendered the protein fragment incapable of binding 
metals and this therefore implicates the histidine residues as 
necessary donor ligands for metal binding. 
The DEPC modification is reverted by hydroxylamine (NH20H), 
regenerating the histidine residues (Melchior & Fahrney, 1970). The 
hydroxylamine-treated-DEPC-flbrin-D-dimer yielded a characteristic 
absorption band in the visible region with molar extinction coefficient 
of 168.65 M· lcm· l when titrated with cobalt(II). The regeneration of 
the histidine residues therefore restored metal binding properties to 
the protein and the complex generated is characterised as tetrahedral 
similar to the native Co-flbrin-D-dimer complex. This confirms 
unequivocally that zinc binds to f-D-dlmer with the liganding histidine 
residues in a tetrahedral geometry. 
A Model for the Zinc induced Neoepitope 
The evidence presented indicates that histidine residues in 
flbrin-D-dimer bind one zinc per molecule in a tetrahedral 
configuration in a manner that potentiates the site specific cleavage of 
the molecule in the crosslink region by a snake venom protease. Zinc 
potentiates the cleavage of the di-y-chain between G-404 and A405 on 
both chains and titration with zinc also increases the extrinsic 
fluorescence of the 
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Figure 34: Proposed model for the zinc induced neo-epitope of 
ftbrin-D-dimer. The figure represents the crosslink region of 
ftbrin-D-dimer before (1) and after (2) the binding of zinc. The 
solid bars represent the transglutaminase induced isopeptide 
crosslinks between g399 and K406, n represents the 
continuation of the peptide to the N-terminus, c is the carboxy 
terminus of the chain and * represents the zinc(II) ion. 
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Crosslink with Zinc 
Computer model of the crosslink peptide of flbrtn-D-dimer with Zinc (supra). 
The zinc atom is llganded to 4 histidine residues (see text). The Factor XIII 
induced crossllnks are boxed. The residues of the two y chains are labelled 
X and X' respectively. It is apparent from this model that the GOA peptides 
are forced to the pertphe:ry of the molecule and are thus easily accessible for 
PAV protease cleavage. 
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macromolecule (possibly by inducing a localised change in the 
dielectric constant or relative permittivity in the immediate 
environment of the fluorophore). 
The proposed model for this zinc-induced new conformation would be 
as follows: zinc is bound within the crosslink region of the di-y-chain 
of the protein molecule coordinated to two pairs of adjacent histidine 
residues H-401 and H-402 on each of the antiparallel crosslinked 
protein y-chains. The zinc atom is liganded to the histidines via thee 
nitrogen of the histidine imidazole rings creating a strained 
tetrahedral geometry about the zinc ion (Fig.34). 
The imidazole ring is abnormally basic for a compound with a sp2 
hybridized nitrogens (pKa = 7.0, Kb_= 1.6 x 10-7). This is due to the 
symmetry of the conjugated acid and the consequent resonance 
stabilisation. The mesomeric effect in particular affords histidine an 
enhanced proton acceptor status with excellent liganding properties 
for zinc under physiological conditions (Streitweiser & Heathcock, 
1981). 
The liganding histidines are adjacent and therefore lack spacer 
sequences so that the coordination with the metal cation induces 
localised strain in the peptide chain. Relief of strain requires a 
rearrangement of the di-y-chain crosslink region to allow the zinc 
coordination capsule to achieve a tetrahedral geometry. The geometry 
would not be a perfect classical tetrahedron but distorted tetrahedron 
succumbing to physical constraints and the limitations of the 
Jahn-Teller effect. 
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The proposed structure (Fig.34) is further stabilised by the 
hydrophobic interactions between the imidazole rings and 
neighbouring leucine isobutyl side chains. The nett result of this 
conformational change of the di-y crosslink peptide is the exposure of 
the distorted G-404 - A405 peptide bond on the outer periphery of the 
molecule. An unusual site specificity (between two glycines and an 
alanine residue) is thereby created by virtue of this conformation 
despite the lack of significant side chain residues. 
The biphasic nature of the protease digestion of the f-D-dimer may 
now be explained. The initial cleavage on one of the y-chains occurs 
rapidly accompanied by a proportional change in the hydrophobic 
environment of the dansylcadaverine fluorophore and the subsequent 
increased solvent fluorophore collisions. This accounts for the initial 
sharp decrease in absolute fluorescence. This first cut also results in 
great reduction of conformational strain on the molecule. The 
consequent relaxation of the molecule renders the cleavage site on the 
second y-chain less accessible and therefore less susceptible to 
cleavage. 
This accounts for the 9-fold slower reaction rate for the second phase 
of the digestion (krast = 0.91 min-1 vs kslow = 0.01 min-1 ). 
Physiological Significance. 
The plasma zinc concentration in normal individuals is in the range of 
10.7 - 16.9 µM (Failla, 1982). Thirty five percent is tightly bound to 
a-2-macroglobulin (Parisi, 1970) and a large percentage of the 
remainder is in zinc enzymes and zinc proteins resulting in a very low 
free zn2+ concentration in plasma. Given that albumin binds zinc 
fairly strongly, pk= 6.98, n = 1, it would be fair to assume that 
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albumin is probably responsible for binding a major fraction of free 
zinc in human plasma (Marx, 1988). The binding constant we 
calculated for zinc binding to fibrin D-dimer is of the order of 
pk= 3.88, therefore, offers weak competition to albumin for zinc(II) 
ions. This could mean that the physiological significance in vivo is 
minimal. However, if one speculates that in the case of a puffadder 
bite, the venom injection contains a rich load of divalent cations, this 
may increase the free zinc ion concentration locally to sufficiently high 
levels to render the postulated zinc potentiated substrate effect 
physiologically significant. In addition there may well be a 
collaborative mechanism in plasma with high concentration divalent 
cations eg. calcium(II) and zinc released from platelets .. 
The in vitro significance of zinc binding to fibrin-D-dimer is less 
speculative. It can be concluded from the zinc induced intrinsic 
fluorescence changes and the volume changes that zinc(II) ions induce 
a considerable conformational change in the fibrin-D-dimer structure. 
Scatchard plots put the zinc:fibrin-D-dimer stoichiometry at 1: 1 and 
infers a pk of 3.88. We conclude that a novel fibrin-specific epitope 
could be manifest in the presence of zinc ions and could provide a 
means to determine fibrin degradation products more specifically. 
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ADDENDUM I: Derivation of the Scatchard Equation 
Consider the ca~e of a macromolecule M, which contains n binding sites for 
ligand L. Each site has the same microscopic ligand dissociation constant kd. 
The binding sites are assumed to be independent, ie. the microscopic 
dissociation constant k for a particular site is the same regardless of the 
occupancy of the other sites. The equilibrium ch~acterising the ligand binding 
interaction would read as follows: 
M0 +L ~ M1 
M1 + L ;:::=! M2 
Mn-1 + L= Mn 
The yield of moles of ligand bound for molecule of macromolecule, 
designated 'f. would be given by 
y -
If we consider the equilibrium of the site i only, and let 91 be the 
fractional saturation of the site 1, then 
01 = (Bound site i)/[(Free site 1) + (Bound site 1)) 
We multiply the numerator and denominator by 
then, 
( F i--ee s: te A.,) 
( F x.,t s d,t ~) 
Nov.J 
( bouVle-< f.,'k <)/ 
( Free <o; ~, ., · ) 
T t. 121-(, f m, 
T~l,l$ frr M..., 
r:J;. 
L/~~)i 
= 
I + 
.,o,·~~) 'I 
f 
=> IL 
L / ( k"-).,; 
~ 
=L ;. 
Thus generally for each site, 
- L ;f-t,),; 
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ADDENDUM II: Proposed mechanism for the diethylpyrocarbonate mod1ficat1on 
· of histidines and regeneration by hydroxylamine. 
Mechanisms of DEPC modification of Histidines 
The phenomenon of diethylpyrocarbonate modification of histidine residues has 
been reported (Rogers et al, 1977, Melchior & Fahrney, 1970), however, the 
mechanism of the modification has not. Dlethypyrocarbonate or ethoxyformic 
anhydride is a classical ester acid anhydride with the following structure: 
O 0 
!I II C H 3 C H ~ - O - · C.. - 0 - c... - C~ ..l CH., 
The reaction of ethoxy formic anhydride would follow one of two directions. 
A. 
1. The.~thoxyformic anhydride at acid pH values dissociates resulting in the 
formation of a carbocation. 
+ 
-
2. The histidine ring rearranges the localisation of electrons with the E 
nttr.ogen donating its lone pair of electrons resulting in the form,ation of a 
nucleophile. 
3. The nucleophile attacks the electrophile in the classical manner. 
-< -~ h_) h V ~/ 
e~ 
®) 
CH?> GUJ-
This results in the irreversible alkylation of the histidine ring. The inability 
to ligand metals via the E nitrogen would be as a result of steric 
hinderance. While the mechanism is plausible, it seems the less likely 
possibility as the nucleophile could be -easily negated at low pH values by 
spontaneous protonation. This mechanism for modification also does not 
allow for hydroxylamine regeneration, being irreversible, and the alkylated 
histidine could not be the major product of modification. 
B. The mechanism that with result in the dominant product of the recemate 
is more llkely to be as follows: 
A fundamental limitation of this mechanism ts that the pH of the 
reaction be as close to pH 7.00 as possible. These histidines have to 
, be deprotonated, therefore, pH > pKa (His) (pKa _ 6); and to prevent 
the hydroxide ion from becoming the deminant nucleophile, higher 
pH values would not be recommended. 
/ 
l. The deprotonated histidine serves as nucleophile utilising the lane pair of 
electrpns on the epsilon nitrogen. 
A + N t,..I •• 
V 
E.+{o)(0 f Ct'Mj\ f,J e:,-k.,d i'vH. 
Regeneration of Histidine with NH20H 
Histidine is an excellent leaving group. The reaction of ethoxyformyl histidine 
would be most effective at high pH values [pKa (NH20H) = 8). 
1. NH20H adds on to the ethoxyformyl histidine creating an unstable 
transitionary state. 
->-/~(±) 9) 
-<- N N - G - 0 -c..H C~ V / ;, J 
( 
' .. 
/ /" 
N ~\~ o ~ 

ADDENDUM III Crosslink Peptide with Zinc as modelled on DTMM. 
The co-ordination capsule of zinc(II) in the crosslink peptide. The zinc ion is 
liganded to four histidine residues in an almost perfect tetrahedral 
configuration. 
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ADDENDUM IV: Case Report of a Factor XIII deficiency 
A seven year old female presented with abnormal bruising. There was 
umbilical bleeding at birth and probably intracranial bleeding thought to be the 
cause of a degree of mental retardation. Whole blood, plasma and serum 
samples from the patient were tested. Normal clotting times were observed, but 
the clot was soluble in 4M urea indicative of a Factor XIII deficiency (Lorand et 
al, 1980). To confirm the diagnosis, the clot was subject to digestion by 
plasmin in 0.1 M Tris, pH 7.4, 150 mM NaCl and 10 mM CaCl2. The digest was 
analysed by SOS-PAGE (Figure infra). 
The plasmic digest of the patient clot results in D-monomer and E-
fragments with total absence of the characteristic D-dimer fragments. This 
indicates that Factor XIII catalysed crosslinking of the antiparallel y-chains did 
not occur. SOS-PAGE of ~-mercaptoethanol-treated plasmic digest samples 
revealed absence of the di-y-chain, only the y-chain was present, confirming the 
absence of Factor XIII activity. 
1 2 3 4 
D-dimer • 
monomer ... 
• di-gamma 
• gamma 
Figure addendumIV. 6-15%SDS-PAGE of plasmic digests of patient (lane 3) and 
normal(4) clots. Lanes 1 and 2 are standard D-dimer and D-monomer markers 
respectively. 
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